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ABSTRACT 
CHANGES IN GABAA RECEPTOR EXPRESSION AND ALTERATIONS IN 
Ca++/CALMODULIN-DEPENDENT PROTEIN KINASE II ACTIVITY IN A 
HIPPOCAMP AL NEURONAL CULTURE MODEL OF EPILEPSY 
By Robert Eagan Blair, B.S. 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University 
Virginia Commonwealth University, 1998 
Major Director: Dr. Robert J. DeLorenzo, M.D., Ph.D., M.P.H. 
Chairman, Department of Neurology 
Expression levels of GABAA receptor subunits and activity of the Ca++ /calmodulin-
dependent protein kinase II (CaM kinase II) enzyme system were evaluated in an in vitro 
hippocampal neuronal culture model of epilepsy. Treatment of hippocampal neuronal 
cultures with Mg++ -free media for 3 hours results in the induction of an enduring "epileptic" 
state as evidenced by the expression of spontaneous recurrent seizure (SRS) discharge. The 
induction of the SRS activity was shown to be a N-methyl-D-aspartate (NMDA) receptor, 
ca••-dependent mechanism (Sombati and DeLorenzo, J Neurophys., 73 (4), 1995). 
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Significant and long-lasting decreases in mRNA expression for the GABAA a:2 and a:5 
receptor subunits were observed in association with the induction of SRSs in this model, 
while levels for al, p2 and y2 subunits showed no significant change. Irreversible (3H]­
flunitrazepam saturation binding analysis in membrane preparations demonstrated a 
significant decrease in specific binding in association with the SRS activity observed in this 
model. No changes in GABAA P subunit immunoreactivity were detected. Selective 
suppression of the GABAA a:2 subunit protein levels in hippocampal neuronal cultures using 
antisense oligonucleotide technology caused a significant decrease in the amplitude of 
spontaneous inhibitory postsynaptic currents (sIPSC). 
CaM kinase II is highly enriched in the brain and mediates many processes essential 
to neuronal function and viability. Induction of SRSs in hippocampal cultures were 
associated with a long-lasting and significant decrease in activity ofCaM kinase II. Addition 
of2-amino-5-phosphovaleric acid to the low Mg+• treatment solution prevented the decrease 
in CaM kinase II activity. Suppression ofCaM kinase II activity in hippocampal cultures by 
treatment with either an antisense oligonucleotide specific for a CaM kinase II or KN93 
(selective CaM kinase II inhibitor) resulted in significant reductions in IPSC amplitude. This 
data suggests that CaM kinase II can act to regulate GABAergic inhibitory function in 
hippocampal cultures. The findings of this study demonstrate long-lasting decreases in 
GABAA receptor expression and activity of CaM kinase II, which may contribute to the 
induction of the "epileptic" state of this model. 
GENERAL INTRODUCTION 
A. Seizures and Epilepsy: 
A seizure can be defined as the synchronous and uncontrollable firing of a population 
of neurons (Lothman et al., 1991). Seizure discharges are paroxysmal, they have a distinct 
onset and termination. The occurrence of seizure activity does not necessarily indicate a 
permanent alteration in neuronal function, but rather an isolated episode that can be 
precipitated by a variety of insults to the brain. These include trauma, toxins, drug 
withdrawal and metabolic disturbances. A classification of seizures has been developed that 
incorporates data from clinical evaluations and animal models (Lothman et al., 1991 ). 
Partial seizures involve specific brain foci and express themselves by a variety of behavioral 
and motor manifestations. This class of seizures is subdivided into simple and complex, the 
latter involving loss of consciousness. Partial seizures have the ability to propagate 
throughout the brain and become generalized. Generalized seizures involve large areas of 
the brain and are bilateral in nature. Behavioral manifestations that ensue with generalized 
seizures range from loss of consciousness to major motor convulsions (tonic-clonic, clonic, 
or tonic). It has been estimated that approximately 10% of the population will experience 
a seizure at some time during their life (Lothman et al., 1991 ). 
Epilepsy is a condition that displays recurrent seizures over time and affects 
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approximately 1% of the population (Hauser and Hesdorffer, 1990). Unlike a single seizure, 
epilepsy is associated with spontaneous recurrent seizures (SRS) and is the result of a long­
lasting alteration in neuronal function at the cellular level. Although there are a wide variety 
of pharmacological interventions which allow for the successful management of epilepsy, 
the mechanisms that underlie this condition are still unclear. 
B. Mechanisms of Epileptogenesis: 
Epileptogenesis has been attributed to alterations in both excitatory and inhibitory 
synaptic function. Although changes in these two systems, either independently or in 
concert with each other, play an important role in seizure induction at the functional level, 
the multitude of underlying regulatory pathways involved in sustaining the epileptogenic 
phenotype is very complex. Many investigations employing both in vitro and in vivo models 
of seizures and epilepsy have shed light on some of these underlying mechanisms. 
In many seizure models, a significant and well documented phenomenon is the 
observation of selective cell loss in the hippocampus, accompanied by sprouting of mossy 
fibers onto targets that did not receive those inputs previously (Parent et al., 1997). This is 
also seen in brain tissue taken from temporal lobe epilepsy (TLE) patients (Sutula, 1990). 
This "re-wiring" of neuronal circuitry has been shown to predominantly occur in the hilar 
cells of the dentate gyros (DG), a region usually resistant to seizure induction (Parent et al., 
1997). This neurogenesis and aberrant synaptic reorganization leads to an increased number 
of excitatory synapses, culminating in the induction of a hyperexcitable state. The 
potentiation of neuronal excitability is thought to contribute to the pathophysiological 
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manifestations evident in these models (Parent et al., 1997; Sutula, 1990). 
Enhancement of excitatory synaptic transmission in association with the induction 
and maintenance of neuronal hyperexcitability observed with epileptogenesis has been 
another area of intense study. An increase in the function of the N-methyl-D-aspartate 
(NMDA) receptor in the kindling model of epilepsy has been demonstrated (Martin et al., 
1992; Kohr et al., 1993). Induction of both the kindling model of epilepsy (Sutula et al., 
1996) and continuous hippocampal stimulation model of status epilepticus (Young and 
Dragunow, 1994) are dependent on NMDA receptor activation. Stringer and Lothrnan 
(1992) have observed a phenomenon they termed "maximal dentate activation" (MDA) in 
models that displayed seizure afterdischarges. They proposed that the DG acts as a driving 
force for the generation of seizure afterdischarges in the hippocampus and other brain regions 
in the kindling model of epilepsy. Furthermore, it has been demonstrated that MDA is 
dependent on NMDA receptor activation. Addition of MK-801 blocked MDA and 
subsequent afterdischarge generation. In a model of self-sustaining limbic status epilepticus 
(SSLSE) induced by continuous hippocampal stimulation, electrophysiological studies of 
hippocampal slices from animals one month following stimulation, revealed an increase in 
duration of EPSPs compared to controls. Addition of APV (2-amino-5-phosphovaleric 
acid) to the recording solution suppressed the enhancement of EPSPs, suggesting that 
NMDA receptor activation is a contributing factor in the modification of the EPSPs 
evidenced in this model (Lothman et al., 1995). 
Loss of inhibitory function as a mechanism for epileptogenesis has been the focus of 
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much research. Areas of investigation have ranged from loss of innervation of inhibitory 
intemeurons to changes in function ofreceptor systems at the post-synaptic membrane. One 
proposal for the decrease in inhibitory function is the "dormant basket cell hypothesis" which 
concludes that a specific loss of excitatory afferent projections to these GABAergic 
intemeurons in the dentate gyrus renders this inhibitory pathway inactive (Dudek and Spitz, 
1997; Sloviter, 1991 ). However, a recent investigation has shown evidence for an NMDA 
receptor-dependent suppression ofhippocampal inhibition in a model of SE (Mazarati and 
Wasterlain, 1997). 
Many studies have focused on investigating alterations in inhibitory function at the 
postsynaptic membrane. In an in vitro model of kindling in the hippocampal slice, a decrease 
in the long-term depression of evoked inhibitory potentials suggested alterations in function 
of GABAA and GABA8 receptors (Merlin and Wong, 1993) A decrease in paired-pulse 
depression in both the kindling model of epilepsy (Kapur et al., 1989) and the continuous 
hippocampal stimulation model of status epilepticus (Kapur and Lothman, 1989) has been 
demonstrated, suggesting that suppression of GABAergic inhibitory function contributes to 
the underlying mechanisms of seizure propagation in these models. 
Transduction pathways and second messenger systems play an essential role in 
maintaining normal cellular physiology. How alterations in these pathways may contribute 
to seizure generation is a major research question. Several studies have demonstrated an 
increase in activity of the protein kinase C (PKC) enzyme in the kindling model of epilepsy 
(Chen et al., 1992; Kohira et al., 1992). A decrease in the ca++/calmodulin-dependent 
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protein kinase II (CaM kinase II) system was observed in the same model (Bronstein et al., 
1990; Goldenring et al., 1986). CaM kinase II activity is decreased in a bicuculline induced 
model of status epilepticus (Bronstein et al., 1988) and in a continuous hippocampal 
stimulation model of status epilepticus (SE) (Perlin et al., 1992). 
Although immediate changes in cellular components occur during the induction phase 
of seizures and epilepsy, evidence suggests that the long-lived alterations that underlie the 
recurrence of seizure expression are the result of changes at the genetic level. Research has 
been carried out to determine the existence of "epilepsy" genes associated with human 
idiopathic epilepsies, but this task has been difficult in establishing an involvement of the 
genetic linkage with the neuropathological condition (Berkovic and Scheffer, 1997). 
Experimental models of seizures and epilepsy allow for thorough investigation of how 
changes in gene expression contribute to the induction and maintenance of these conditions. 
Induction of selected transcription factors such as c-FOS, c-JUN, KROX, and CREB ( cAMP 
response element binding protein) have been demonstrated in animal models of seizures and 
epilepsy (Herdegen et al., 1993; Labiner et al., 1993). It is thought that the induction of these 
immediate early genes acts to regulate changes in expression of long-term effector genes 
which underlie the maladaptive phenotype of seizures and epilepsy. A number of studies 
have looked at seizures associated changes in effector genes. These include the GABAA 
receptor system (Kamphuis et al., 1995; Kokaia et al., 1994; Rice et al., 1996; Vick et al., 
1996), NMDA receptor system (Kraus et al., 1994; Kraus et al., 1996; Vezzani et al., 1995), 
AMPAIKA (cx-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/kainic acid) receptor 
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expression (Khrestchatisky et al., 1995), ca++/calmodulin-dependent protein kinase II 
(Bronstein et al., 1992), cytoskeletal proteins (Kamphuis et al., 1995), and neurotrophic 
factors (Emfors et al., 1991). 
The general consensus is that there is a loss of balance between the excitatory and 
inhibitory drives that regulate neuronal synaptic transmission. Substantial evidence suggests 
that alterations in GABAergic receptor function contribute towards the decrease in inhibitory 
drive observed with epileptogenesis. The enhancement of selective excitatory receptor 
systems have been shown to occur in seizure models. Potentiation of these pathways results 
in the increased gating of ca++, a major second-messenger in the CNS (central nervous 
system). Changes in intracellular Ca++ levels have been associated with both 
neurophysiological and neuropathological processes (Ghosh and Greenberg, 1995; Chum, 
1995). CaM kinase II is a multifunctional enzyme that is enriched in the brain. Alterations 
in activity of this kinase have been associated with a number of pathological conditions 
(Bronstein et al., 1988; Chum et al., 1992a; Churn et al., 1995; Chum et al., 1997; 
Goldenring et al., 1986; Kochan et al., 1997; Perlin et al., 1992; Wasterlain and Farber, 1984; 
Wasterlain et al., 1992). 
We have chosen to investigate the function and expression of the GABAA receptor 
channel in association with induction and maintenance of epileptogenesis. In addition, the 
role of CaM kinase II in seizure and epilepsy will be investigated. To address these issues, 
we will employ an in vitro hippocampal neuronal culture model of epilepsy. 
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C. In Vitro Model of Spontaneous Recurrent Seizure Activity in Primary 
Hippocampal Cultured Neurons: 
Treatment ofhippocampal cell cultures with a Mg++-free media for three hours results 
in the induction of an enduring "epileptic" state as evidenced by the expression of 
spontaneous recurrent seizure discharge (Sombati and DeLorenzo, 1995). The seizures 
exhibited in this model can be halted by classical anticonvulsant drugs. This blockade is 
reversible, where upon removal of the agent results in resurgence of the seizure discharges. 
This observation would suggest that a long-lived alteration is in place and underlies the 
chronic expression of the pathophysiological condition exhibited in this model. Reducing 
extracellular ca++ to 0.2 mM or applying 50 µM APV during the treatment protocol blocks 
the induction of the "epileptic condition" in these cultures, suggesting an NMDA receptor, 
Ca++-dependent mechanism of epileptogenesis associated with this paradigm. This model 
allows easy evaluation and manipulation of the neuronal culture environment, creating a 
powerful tool for the investigation of the biochemical, biophysical and genetic mechanisms 
that underlie epilepsy and the seizures associated with it. 
D. Structure and Function of the GABAA Receptor Complex: 
The y-aminobutyric acid type A (GABAJ receptor, a member of the ligand-gated ion 
channel superfarnily, is the primary mediator of fast inhibitory synaptic transmission in the 
CNS (Barnard et al., 1987). Upon binding to the endogenous ligand GABA, the receptor 
channel gates the influx of chloride resulting in hyperpolarization of the plasma membrane. 
Activation of the GABAA receptor by selective agents regulates levels of vigilance, anxiety, 
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muscle tension and epileptiform activity. The complexity of GAB AA receptor regulation is 
exhibited by a number of both positive and negative modulatory sites present on the receptor 
channel which include those for GABA agonists/antagonists, benzodiazepines, barbiturates, 
ethanol, neurosteroids, zinc, and picrotoxin (Barnard et al., 1987). 
The GABAA receptor complex is a pentarneric structure composed of protein subunits 
which surround the channel pore. To date, there have been at least thirteen different GABAA 
receptor subunits isolated and cloned from the mammalian brain which include a1.,;, p,_3, y1_3, 
and o (McKeman and Whiting, 1996). Peptide analysis and hydropathy plots have 
determined that each receptor subunit has four transmembrane spanning regions with the 
second region lining the channel pore, a characteristic that is shared with other members of 
the ligand-gated ion channel superfamily (Barnard et al., 1987). Each subunit has a large 
NH2-terrninal extracellular domain which contains characteristics common to other receptor 
proteins in this family such as N-linked glycosylation sites and Cys residues for the formation 
of loops important in binding of GABA or other ligands to the receptor channel. On the 
intracellular side, a large cytoplasmic loop between transmembrane regions 3 and 4 has been 
shown to contain specific consensus sites for protein phosphorylation. This is a poorly 
conserved region among the GABAA subunits, and is thought to engender selective 
regulation of heterogeneous GABAA receptors by different kinase systems (Burt and 
Karnatchi, 1991 ). 
With the initial isolation and cloning of the a and P subunits of the GABAA receptor, 
it was believed that a combination of these two receptor proteins could constitute a functional 
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receptor complex (Barnard et al., 1987). Further studies determined that the addition of the 
y subunit was necessary to confer benzodiazepine sensitivity to the GABAA complex, a 
characteristic common to the native form of the receptor channel. Thus, it was determined 
that the minimum requirement for the subunit make-up of the GABAA receptor was a.P. y x 
(Pritchett et al., 1989). With the large number of isolated and cloned receptor subunits and 
the pharmacological diversity ofGABAA receptor responses observed throughout the CNS, 
it was believed that changes in receptor subunit composition could underly the observed 
heterogeneity of receptor response. Employment of recombinant receptor techniques and 
expression systems in a number of studies have determined the contribution of different 
GAB AA receptor subunits to the diversity of channel function. 
Expression analysis ofhomomeric receptor channels resulted in little or no response 
to applied GABA, suggesting that formation of the GABAA receptor from a single subunit 
is highly unlikely (Sigel et al., 1990). It has been established that the presence of a P subunit 
is required for GABA-dependent gating of the receptor channel and that co-expression of 
both a and y subunits along with p significantly enhances GABA response. Substitution of 
the y2 subunit with either y 1 or y3 in the a1p2 y, combination results in a receptor channel 
with reduced affinity for benzodiazepine agonists (Luddens et al., 1995). Comparison 
between different p subunit isoforms reveal that substitution of Pl with the P2 subunit 
increases the GABA-dependent gating of the receptor channel. These findings would suggest 
that o:, p, and y subunits can independently affect the efficacy of GABA-dependent gating 
of the receptor channel (Sigel et al., 1990). With regards to benzodiazepine sensitivity of the 
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GABAA receptor complex, expression studies have determined that a variation of expression 
within the a subunit family controls the designation of either a high affinity (Type I) or low 
affinity (Type Il) benzodiazepine/GABA receptor. Co-expression of the al subunit with the 
p1 y2 combination resulted in a receptor channel displaying characteristics of a high affinity 
receptor channel. Substitution of the al with either a2, a3, or a5 resulted in a low affinity 
receptor channel (Pritchett et al., 1989). 
Even though the theoretical number of possible GABAA receptors formed from 
different combinations of the known subunits exceeds 100,000, it is believed that fewer than 
100 different arrangements of the receptor complex exist in the native form. Many studies 
have been directed towards understanding the subunit makeup of GABAA receptors 
throughout the nervous system. 
Using data obtained from in situ hybridization analysis, immunohistochemistry, 
immunopurification of native receptors and receptor binding studies, researchers have been 
able to decipher the region specific variations in subunit composition of GABAA receptors. 
Expression patterns for the al subunit are the most ubiquitous of the GABAA receptor 
subunits and most always co-assemble with the p2 and y2 subunits. Integrating 
benzodiazepine binding analysis with regional expression patterns of the GABAA receptor 
subunits indicates that the a I, p2, and y2 subunits co-localize throughout the brain and form 
the high affinity BZ receptor; this subunit combination is believed to constitute up to 50% 
of all GABAA receptors in the CNS (McKernan and Whiting, 1996). Regional distribution 
of low affinity BZ receptor binding parallels expression patterns for the a2, a3 and aS 
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receptor subunits. In the hippocampus, a2 and a5 are thought to co-assemble with !32/3 and 
y2 subunits to make up the majority ofGABAA receptors in this region (Wisden et al., 1992). 
Although the exact stoichiometry of native GABAA receptors is not yet known, integration 
of the findings from recombinant receptor analysis, subunit expression patterns and binding 
analysis will bring us closer to understanding which GABAA receptor subtypes actually exist 
in the brain. 
E. Phosphorylation-dependent Regulation of GABA A Receptor Function: 
One means of regulating GABAA receptor function is via post-translational 
modification of the receptor subunit proteins in a phosphorylation-dependent manner. All 
of the GABAA receptor subunits have been shown to contain at least one consensus site for 
phosphorylation by selective kinases. These include Ca++-phospholipid-dependent kinase 
(Moss et al., 1992a; Krishek et al., 1994), cAMP-dependent protein kinase (Moss et al., 
1992a; Feigenspan and Bormann, 1994), protein-tyrosine kinase (Valenzuela et al., 1995), 
cGMP-dependent kinase and calcium/calmodulin-dependent protein kinase II (McDonald 
and Moss, 1994). In a purified GABAA receptor preparation, it has been demonstrated that 
phosphorylation occurs on serine, threonine and tyrosine residues in selective polypeptides 
which co-migrated with [3H]-flunitrazepam labelled bands. Using a monoclonal antibody 
specific for the GABAA a receptor proteins, it has been demonstrated that the phosphate 
incorporation occurs on this subunit class of the receptor channel (Bureau and Laschet, 
1995). Phosphorylation of GABAA receptor subunits can result in either enhancement or 
suppression of the GABAergic inhibitory response. Furthermore, different signal 
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transduction pathways have been shown to incur opposite effects on GABAA receptor 
function. In general, activation of both protein kinase A (Moss et al., 1992b)and protein 
kinase C (Krishek et al., 1994) pathways result in attenuation of GABA-activated currents. 
Contrary to these findings, Feigenspan and Bormann (1994) employing a retinal amacrine 
cell preparation, demonstrated that activation of the protein kinase A pathway augmented 
GABAergic inhibitory function. These discrepancies may be due to regional variations in 
the subunit composition of the GABAA receptor observed throughout the CNS (Wisden et 
al., 1992). Activation of tyrosine kinase ('1 alenzuela et al., 1995), cGMP-dependent kinase 
(Leidenheimer, 1996), and Ca++/calmodulin-dependent protein kinase II (Kano et al., 1996; 
Wang et al., 1995) pathways results in increased GABAA receptor function. These findings 
demonstrate the complexity involved in post-translational regulation of the GABAA receptor 
channel. 
Modulation of GABAA receptor function also occurs via activation of selective 
phosphatase pathways. Chen and Wong (1994) have shown that intracellular perfusion of 
an active form of calcineurin (calcium-dependent phosphatase) into acutely isolated 
hippocarnpal neurons, resulted in the depression of GABAA responses. They showed that 
NMDA-dependent calcium influx suppressed the GABAA response. Tbis suppression could 
be blocked by addition of okadaic acid (phosphatase inhibitor) or by replacement of 
intracellular ATP with ATP-y-S (non-hydrolyzable form of ATP). Stelzer and Shi (1994) 
demonstrated similar findings, indicating an NMDA receptor, Ca++-dependent mechanism 
in reduction of GABAA responses. In addition, influx of Ca++ via activation of VSCCs did 
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not result in a decrease in GABAA response. These results suggest that calcineurin decreases 
GABAA receptor function in an NMDA/Ca
++-dependent manner. 
F. Alterations in GABAergic Inhibitory Function in models of Seizure and 
Epilepsy: 
Although it is generally accepted that a decrease in inhibitory drive occurs in models 
of seizure and epilepsy, a more thorough investigation of the alterations in inhibitory 
processes is needed to understand the molecular mechanisms underlying these conditions. 
Using the in vitro hippocampal neuronal culture model of spontaneous recurrent seizures 
(Sombati and DeLorenzo, 1995), Gibbs et al. (1997b) demonstrated a seizure associated 
decrease in GABAA receptor function. Both GABA response and affinity for the 
benzodiazepine clonazepam were suppressed in this model. In the rat pilocarpine model of 
temporal lobe epilepsy, the same group evaluated GABAA receptor function in acutely 
isolated CA 1 and dentate granule hippocampal neurons from control and seizure rats. They 
found an enhancement and a suppression of receptor response in dentate gyrus and CA 1 
regions respectively (Gibbs et al., 1997a). These findings support earlier work by Kamphuis 
et al. (1992) using paired-pulse depression analysis of inhibitory function from kindled rat 
hippocampal neurons. This study demonstrated both attenuation and augmentation of 
GABAA receptor function in CAI and dentate granule cells respectively. 
Using the continuous hippocampal stimulation model of status epilepticus, Kapur and 
Lothman (1989) found a decrease in paired-pulse depression and showed that the loss of 
GABAergic inhibition could be directly correlated with the severity of spontaneous seizures 
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exhibited by each animal. Changes in properties of several of the allosteric modulatory sites 
present on the GABAA receptor complex have been shown to occur in models of seizure and 
epilepsy. These include a decrease in benzodiazepine sensitivity (Kapur and Macdonald, 
1997), a decrease in [3H]-muscimol binding (Rice et al., 1996; Kapur et al., 1994) and 
changes in zinc sensitivity (Buhl et al., 1996; Kapur and Macdonald, 1997). Investigations 
are warranted to determine the molecular mechanisms that underlie the maladaptive state of 
GABAA receptors in these pathophysiological conditions. 
G. Alterations in GABA A Receptor Subunit Expression in Models of Seizure and 
Epilepsy: 
A direction currently being taken to elucidate the underlying mechanisms of seizures 
and epilepsy is the study of how alterations in the level ofrnRNA expression for selective 
GABA A receptor subunits is involved in these conditions. Rice et al. (1996) employed a rat 
pilocarpine model of temporal lobe epilepsy and demonstrated a long-lasting decrease in 
mRNA levels for the a2 and a5 GABAA receptor subunits in hippocampal CA1-CA3 
regions. No changes in expression levels for the a 1, �2, or y2 subunits were observed. In 
agreement with these findings, in situ hybridization analysis revealed a decrease in GABAA 
a2 mRNA expression in an in vitro hippocampal slice model oflow-Mg++ induced stimulus­
evoked seizures (Vick et al., 1996). 
In the kainic acid model of temporal lobe epilepsy, a decrease in GABAA al mRNA 
expression in the CA3/CA4 region of the hippocampal formation has been observed and 
precedes the neurodegeneration seen in this model (Friedman et al., 1994). Analysis of 
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GABA A Pi.; subunit expression levels in the hippocampus of electrically kindled rats was 
carried out by Kamphuis et al. (1994). Region-specific changes in mRNA levels within the 
hippocampal formation were detected and reflected by small and opposing changes of p I and 
p2 (increase and decrease respectively) in CAI and CA3 neurons, while in fascia dentata 
region a robust increase in P3 levels was evident. Additional work from the same group 
involved a more extensive investigation of GABAA receptor subunit expression in the same 
model at different stages of the kindling process; acquisition, 24 h after the last seizure and 
28 days following completion of the kindling paradigm. During the acquisition phase of 
kindling, they found that most of the subunits (al, a2, and a4, P 1•3, and y2S/2L) 
demonstrated an increase in expression in both CA and DG regions of the hippocampus. 
One day post- induction of the fully kindled state, most GABAA receptor subunit mRNA 
levels had returned to control levels with the exception of P3 and y2S/2L levels which 
remained elevated. Long-term analysis revealed only a slight decrease in the y2L subunit 
in the fascia dentata region of the hippocampus (Kamphuis et al., 1995). 
The findings suggest that altered receptor subunit composition may contribute to the 
modification of GABAergic inhibitory processes seen in these models. An interesting 
observation is the paralleled increase in both GABAA receptor response and selected receptor 
subunit expression levels in the hippocampal dentate granule cells in these models, whereas 
in the CA regions, a decrease in GABAA receptor function and subunit mRNA levels have 
been shown. 
H. Ca*/Calmodulin-dependent Protein Kinase Il: 
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Calciwn/calmodulin-dependent protein kinase 11 (CaM kinase II) is a multifunctional 
enzyme involved in regulating many Ca++ -dependent processes throughout the CNS 
(Bronstein et al., 1993). Phosphorylation of substrates by CaM kinase 11 underlies its 
modulation of many cellular functions including neurotransmitter biosynthesis and release, 
cytoskeletal structure, ligand-gated and calcium-dependent ion channels and transcriptional 
regulation (Churn, 1995). The ability of CaM kinase 11 to enhance synaptic function via 
phosphorylation of specific glutamatergic receptor channels implicates its involvement in 
long-term potentiation (L TP), a model of learning and memory (Soderling, 1993). The 
holoenzyme is composed of two subunits termed a and P with apparent molecular weights 
of 50 and 60 kDa (kilodaltons) respectively (Goldeming et al., 1983). 
A unique characteristic of CaM kinase II is that upon activation by Ca<+ and 
calmodulin, the enzyme undergoes autophosphorylation, rendering it ca++/calmodulin­
independent. Autophosphorylation allows CaM kinase II to regulate itself and allows for 
prolonged activity of the enzyme until selected phosphatases act to return it to its inactive 
form. CaM kinase II is expressed abundantly throughout the CNS comprising approximately 
l % of total brain protein and up to 2% of total hippocampal protein (Erondu and Kennedy, 
1985). The a subunit of CaM kinase II has been designated the major postsynaptic density 
(PSD) protein, contributing up to 50% of the total protein in this complex. The PSD is an 
electron dense region localized at the postsynaptic membrane of excitatory synapses and is 
believed to be involved in maintaining structure and function of the postsynaptic complexes 
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(Churn, 1995). The actions of CaM kinase II in regulating so many neurophysiological 
processes demonstrates the essential function this enzyme serves in maintaining cellular 
viability. 
I. CaM Kinase II in Models of Neuropathology: 
Considering the important role that CaM kinase II plays in many neurophysiological 
processes, one might expect that alterations in CaM kinase II activity could provoke 
neuropathological circumstances. A decrease in forebrain CaM kinase II activity has been 
shown to occur immediately following ischemic insult in the gerbil model of ischemia, 
preceding the delayed neuronal cell death noted with this model (Churn et al., 1990; Churn 
et al., 1992a; Churn et al., 1992b). NMDA-dependent excitotoxicity in primary neuronal 
cultures results in a reduction in activity ofCaM kinase II in both hippocampal (Churn et al., 
1995) and cortical (Churn et al., 1995; Churn et al., 1993b) neurons. Several studies have 
correlated the extent of excitotoxicity-induced neuronal cell death with the degree of 
suppression of CaM kinase II activity. Churn et al. (1990) have shown that hypothermia­
induced blockade of ischemic neuronal cell death in gerbil brain also results in preservation 
of CaM kinase II activity. Hanson and colleagues ( 1994) have demonstrated, using a focal 
ischemia model in rat brain, that the decrease in level of neuronal death observed with 
increased distances from the ischemic core parallels the changes in CaM kinase II activity 
seen in this model. The evidence strongly suggests a role for alterations in CaM kinase II 
function mediating the aberrant cellular events in excitotoxicity which ultimately result in 
the neuronal death associated with these models. 
J. Alterations in CaM kinase II in Models of Seizures: 
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In models of seizures and epilepsy Ca++ -dependent regulatory processes have been 
suggested to play an essential role in the induction and maintenance of the pathophysiology 
observed (DeLorenzo, 1986). The role of CaM kinase II in regulating seizure conditions was 
first considered because of the ability of anticonvulsant agents to inhibit Ca++/calmodulin­
dependent protein phosphorylation and neurotransmitter release (DeLorenzo, 1984). A 
number of laboratories have studied the function of CaM kinase II in association with the 
initiation and maintenance of seizure expression using a variety of in vivo and in vitro model 
systems. Treatment ofhippocampal slices with Mg++ -free media results in the expression 
of epileptiform activity with a concurrent decrease in activity of CaM kinase II (Churn et al., 
1991). 
A decrease in the function of CaM kinase II in association with status epilepticus 
(SE) has been observed in a number of studies (Bronstein et al., 1988; Perlin et al., 1992) 
Using a continuous hippocampal stimulation (CHS) paradigm to induce status epilepticus 
in the rat, Perlin et al. (1992) have shown a significant decrease in activity of CaM kinase II. 
The status epilepticus-induced suppression of CaM kinase II directly correlates with the 
progressive intensity of electroencephalographic discharges recorded from SE rats. Several 
studies have demonstrated a decrease in function of CaM kinase II associated with the 
kindling model of epilepsy in the rat (Goldenring et al., 1986; Wasterlain and Farber, 1984). 
A decrease in the expression of CaM kinase II mRNA has been found acutely in a model of 
recurrent limbic seizures (Murray et al., 1995) and long-term in the kindling model of 
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epilepsy (Bronstein et al., 1992). In light of the results presented from these investigations, 
chronic decreases in function of CaM kinase II occur with seizures and epilepsy and may 
contribute to the underlying mechanisms of these conditions. 
K. CaM Kinase II Regulation of GABAA Receptor Function: 
Consensus sequences for CaM kinase II-dependent phosphorylation have been found 
in P l ,  P2 and y2 GABAA receptor subunits (McDonald and Moss, 1994). A number of 
studies have shown enhancement of GABAA receptor function by activation of the CaM 
kinase II pathway. Using both spinal dorsal horn neurons and CAI hippocampal neurons, 
Wang et al. (1995) demonstrated that an intracellularly applied auto-phosphorylated form of 
o:-CaM kinase II increased GABA currents, sensitivity to the GABAA receptor agonist 
muscimol and inhibitory postsynaptic potential (IPSP) amplitude in CAI neurons. In a 
cerebellar Purkinje cell neuronal model, activation of excitatory synaptic input induces a 
rebound potentiation of GABA-mediated currents (Kano, 1994). Studies were carried out 
to determine the pathway(s) involved in inducing the change in inhibitory response 
associated with this model. First, it was demonstrated that incubation with the calcium 
chelator BAPTA ([l ,2-bis(2)-aminophenoxy]ethane-N,N-N',N'-tetraacetic acid) blocked 
the potentiation of GABA-mediated currents, suggesting a calcium-dependent mechanism. 
Addition of staurosporine (non-selective kinase inhibitor) or KN62 (selective CaM kinase 
II inhibitor) both resulted in a blockade of the rebound potentiation. Secondly, the addition 
of calyculin-A (inhibitor of protein phosphatase I and 2A) significantly enhanced GABA­
induced currents in Purkinje neurons, suggesting a phosphorylation-dependent mechanism. 
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Finally, it was demonstrated that intracellular application of a purified and active form of 
CaM kinase II into Purkinje neurons resulted in dramatic augmentation of GABA responses 
(Kano, 1994). Churn and DeLorenzo (1996) have demonstrated that addition of purified rat 
brain CaM kinase II to synaptic membrane preparations acts to dramatically increase [3H]­
muscimol binding. The increase in muscimol binding can be blocked by selective inhibitors 
of CaM kinase II. These findings strongly suggest a role for CaM kinase II in the positive 
modulation of GABAA receptor function. 
L. Summary and Rationale 
Epilepsy and seizures represent a major dilemma in healthcare today and affects 
approximately 1 % of the adult population (Hauser and Hesdorffer, 1990). Advancement has 
been made in the successful management of epilepsy with the use of pharmacological 
intervention, but relatively little is known about the maladaptive processes that are 
responsible for this condition. The underlying mechanisms of epileptogenesis have been the 
focus of many research studies, encompassing the examination of a broad range of cellular 
processes. These include regulation of excitatory and inhibitory receptor systems, signal­
transduction pathways, synaptic reorganization and transcriptional control of long-term 
genes. Considering the complexity of the cross-talk and intra dependency that many of these 
cellular processes possess, it is likely that alterations in a number of these systems are 
involved in the generation and propagation of seizures. 
One direction of investigation has been the study of modifications in GABAergic 
function as a contributing factor to seizure production. A decrease in inhibitory drive 
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associated with seizures has been well established in a number of models. Using the in vitro 
hippocampal neuronal culture model of spontaneous recurrent seizures (Sombati and 
DeLorenzo, 1995), Gibbs and colleagues (1997b) demonstrated a decrease in GABAA 
receptor response to both GABA and the benzodiazepine clonazepam. The underlying 
cellular alterations responsible for the long-lived change in GABAA receptor function 
observed in these hippocampal neuronal cultures and other models of epilepsy have yet to 
be determined. 
Another direction in elucidating the mechanisms of epileptogenesis has been the 
study of Ca++ /calmodulin-dependent protein kinase II, a major ca++ second messenger system 
that regulates many neuronal functions. Due to the multifunctional nature of CaM kinase 
II, alteration of this enzyme system would be expected to invoke abnormal changes in 
cellular function. Changes in CaM kinase II activity have been associated with a number of 
models of neurotrauma. In particular, a number of studies have demonstrated a decrease in 
CaM kinase II function associated with the induction and maintenance of seizures and 
epilepsy. 
M. Hypothesis 
The hypothesis to be tested in this dissertation is: To determine 1) if alterations in the 
GABAA receptor system are associated with the induction and long-term expression of the 
"epileptic condition" exhibited in the hippocampal neuronal culture model of recurrent 
spontaneous seizures, and 2) if modification of the multifunctional CaM kinase II enzyme 
system is associated with the propagation of aberrant activity in this model. The conclusion 
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of this dissertation will involve investigating the relationship between CaM kinase II activity 
and regulation of GABAergic inhibitory processes in primary hippocampal neuronal cultures. 
The experiments in this thesis study will be directed towards testing this hypothesis. 
DECREASED GABAA RECEPTOR EXPRESSION IN AN IN VITRO 
IDPPOCAMPAL NEURONAL CULTURE MODEL OF RECURRENT 
SPONTANEOUS SEIZURE 
A. INTRODUCTION: 
y-Aminobutyric acid (GABA) acts to mediate inhibitory processes throughout the 
brain by its action on GABAA and GABA8 receptors (Bowery et al., 1987). Nearly every 
neuron in the brain responds to GABA in a inhibitory fashion, as well as non-neuronal cells 
such as glia (Burt and Kamatchi, 1991). Suppression of inhibitory mechanisms by 
modulation of GABAA receptor function has been suggested to contribute to the 
neuropathological conditions of seizures and epilepsy. This theory ofepileptogenesis can 
be postulated by several lines of evidence. First, many of the pharmacological agents used 
to manage seizures and epilepsy act at the GABAA receptor to augment the inhibitory 
function of the chloride channel and secondly, convulsant agents such as picrotoxin or 
bicuculline produce their effects by antagonizing GABAA receptor function. A substantial 
amount of research has been conducted to investigate modifications in GABAergic inhibitory 
processes in models of seizures and epilepsy. One theory termed the "dormant basket cell 
hypothesis" suggests that a selective seizure-induced loss of excitatory neurons in the dentate 
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gyrus and subsequent removal of their afferent projections onto GABAergic intemeurons, 
results in a hindrance of the inhibitory pathway from this region (Dudek and Spitz, 1997). 
Such a mechanism implies that the inhibitory mechanisms remain intact, but are incapable 
of being activated. 
Another direction of epilepsy research involves investigating postsynaptic 
mechanisms of seizure induction; specifically modifications of the GABA A receptor channel. 
Indications of seizure associated changes in GABAA receptor function include a decrease in 
benzodiazepine sensitivity (Kapur et al., 1994; Kapur and Macdonald, 1997), reduction in 
muscimol binding (Rice et al., 1996), suppression of inhibitory conductances (Merlin and 
Wong, 1993), and increased Zn++ sensitivity (Buhl et al., 1996). A reduction in paired-pulse 
depression, an indicator ofGABAergic inhibitory function, has been demonstrated in both 
the continuous hippocampal stimulation model of SE (Kapur and Lothman, 1989) and the 
kindling model of epilepsy (Kapur et al., 1989). Although there has been much progress in 
understanding epilepsy-associated changes in GABAA receptor function, the underlying 
molecular mechanisms of these maladaptations still remain unclear. 
Molecular cloning studies have recently demonstrated the existence of at least 13 
different GABAA receptor subunits throughout the CNS which include 6 as, 3 Ps, 3 ys and 
l o (McKeman and Whiting, 1996). The diverse expression patterns for each subunit 
parallels region-dependent variations in GABAA receptor function, indicating that receptor 
subunit composition underlies functional heterogeneity. Expression studies have 
demonstrated differential sensitivity ofrecombinant GABAA receptors to benzodiazepines 
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dependent on which ex subunit is present in the receptor complex (Luddens et al., 1995). The 
regional expression of the ex 1 subunit parallels high affinity (Type I) BZ (benzodiazepine) 
binding. It is believed to primarily co-assemble with the P 2 and y 2 subunits, a receptor 
combination that displays diffuse distribution and is estimated to constitute greater than 50% 
of all GABAA receptors in the brain. Low affinity (Type II) BZ receptor binding exhibits a 
more selective distribution pattern concentrating primarily in the hippocampus, striatum and 
spinal chord, correlating with ex 2, a 3, and a 5 subunit expression patterns (Burt and 
Kamatchi, 1991). The differential subunit expression and functional diversity ofGABAA 
receptors observed throughout the brain suggest that transcriptional control may be a primary 
means of regulating receptor heterogeneity. 
Seizure induced alterations in transcriptional control of GABAA receptor subunit 
expression could contribute to the neuropathophysiological consequences associated with the 
epileptic condition. A number of investigations have studied changes in expression levels 
for selected GABAA receptor subunit mRNAs in models of seizure and epilepsy. A long­
lasting decrease in mRNA expression for selected GABAA receptor subunits has been shown 
to be associated with persistent SRSs in pilocarpine-induced epileptic animals (Rice et al., 
1996) and in low Mg .. -evoked SRSs in hippocampal entorhinal cortical slices (Vick et al., 
1996). Changes in the expression levels for GABAA receptor subunit mRNA have also been 
demonstrated in the kainic acid model of temporal lobe epilepsy (Friedman et al., 1994) and 
electrically-induced kindling model of epilepsy (Kamphuis et al., 1994). In addition to 
changes in GABAA receptor expression, increase in the expression of selected transcription 
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factors such as c-FOS, c-JUN, KR.OX, and CREB have been shown to occur in the early 
phases of epileptogenesis (Herdegen et al., 1993; Labiner et al., 1993). These immediate 
early genes (IEGs) are responsible for regulating transcriptional control and expression of 
Jong-term effector genes. Alterations in regulation of these factors could contribute to long­
lasting maladaptations in neuronal function. 
To investigate the effect of epileptogenesis on GABAA receptor subunit expression, 
we have employed the hippocampal neuronal culture model of epilepsy (Sombati and 
DeLorenzo, 1995). Treatment ofhippocampal cell cultures with a Mg++-free media for three 
hours results in the induction of an enduring "epileptic" state as evidenced by the expression 
of spontaneous recurrent seizure (SRS) discharges. The seizures exhibited in this model can 
be halted by classical anticonvulsant drugs; this blockade is reversible, where upon removal 
of the drug results in resurgence of the seizure discharges. A permanent and long-lived 
alteration is in place in this model and underlies the chronic expression of the 
pathophysiological condition. Reducing extracellular ca++ to 0.2 mM or applying 50 µM 
APV during the treatment protocol blocks the induction of the "epileptic" condition in these 
cultures, suggesting an NMDA receptor, ca++-dependent mechanism is involved in the 
induction of SRS activity evidenced in these hippocampal cultures. The ability to easily 
evaluate and control the neuronal culture environment makes this model a powerful tool for 
the investigation of the biochemical, biophysical and genetic mechanisms that underlie 
epilepsy and the seizures associated with it. 
B. METHODS: 
Primary Hippocampal Neuronal Cultures: 
27 
Primary hippocampal cultures were prepared by a modification of the method of 
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from 
2-day postnatal Spague-Dawley rat pups were dissected out from the brain and placed into 
phosphate buffered saline (PBS) dissection solution containing: 33.0 mM glucose, 43.8 mM 
sucrose, penicillin (50 units/ml)/streptomycin (50 µg/ml), IO mM N-2-
hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES), (pH 7.3) and adjusted to 325 
mOsm with sucrose. Meningeal tissue was stripped away under 40X magnification using 
a Zeiss dissecting microscope (Zeiss, West Germany) and hippocampi were then transferred 
to dissection saline containing 0.25% trypsin (Gibco BRL, Gaithersburg, MD) and incubated 
at 37 °C for 20 minutes for enzyme digestion. Trypsinized hippocampi were washed with 
dissection saline (no trypsin), brought up to a 2.0 ml volume with 10% fetal bovine serum 
in minimum essential medium (MEM) (Gibco BRL, Gaithersburg, MD) containing penicillin 
(SO units/ml)/streptomycin (SO µg/ml) and triturated by passing through a Pasteur pipet. 
Trituration involved passing the hippocampal tissue suspension through the pipet 20 times 
and then allowing suspension to pellet. Dissociated hippocampal cells were drawn off and 
pooled. The peUet was adjusted to a 2.0 ml volume and re-triturated. This procedure was 
repeated two more times until very little tissue pellet was remaining. Viable hippocampal 
cells were counted using cresyl violet blue exclusion analysis with a hemocytometer on a 
Nikon TMS microscope at 200X magnification (Nikon, Japan) and the suspension was 
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adjusted to I x I 06 cells/ml. Hippocampal cells were plated at a density of 2 x 105 cells/35 
mm culture dish (Nalge Nunc International, USA). Prior to plating, dishes were coated with 
10 µl of growth factor reduced MA TRI GEL® matrix (Collaborative Biochemical, Bedford, 
MA) to aid in the attachment of the hippocampal cells. Hippocampal cells were plated in 
MEM containing N3 supplement media, 10% horse serum, 20% conditioned media and 
penicillin (50 units/ml)/streptomycin (50 µg/ml). The N3 supplement contained: 25 mM 
HEPES buffer (pH= 7.4), 2 mM glutamine, 5 µg/ml Insulin, 100 µglml transferrin, 100 µM 
putrescine, 30 T)M sodium selenite, 20 T)M progesterone (ICN, Costa Mesa, CA), 1 mM 
sodium pyruvate, 0.1 % ovalbumin, 20 t]g/ml T3 (Calbiochem, San Diego, CA), 40 T)g/ml 
corticosterone (ICN, Costa Mesa, CA). Unless indicated, all other constituents of the N3 
supplement were acquired from Sigma Chemical Co., St. Louis, MO. One day following 
plating, the media was replaced with N3 supplement containing 20% conditioned media and 
5 µM cytosine arabinoside to inhibit further non-neuronal cellular proliferation. After two 
days of incubation in 5 µM cytosine arabinoside, media was replaced with N3 supplement 
containing 20% conditioned media. The hippocampal cultures were maintained in this media 
for the remainder of the study and were fed with Y, change of media at one week intervals. 
Conditioned media was obtained from confluent hippocampal glia beds plated out at a 
density of l.Oxl06 cells/75 cm2 flasks and maintained in MEM containing 10% fetal bovine 
serum and 2 mM glutamine. Glial cell beds reached confluence 10 days after plating and 
were fed with full change of media twice weekly. Both hippocampal cell cultures and glia 
beds were maintained at 37 oC under 5% CO2 95% air. 
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Mg++-free Treatment ofHippocampal Cell Cultures: 
After two weeks in culture, maintenance media was replaced with exposure solution 
containing (in mM): 145 NaCl, 2.5 KCI, 10 HEPES, +/- 1 MgCl2, 2 CaCl2, 10 glucose, .002 
glycine, pH 7.3, and osmolarity adjusted to 325m0sm with sucrose. Cells were washed 
gently with 3 x 1.5 ml of exposure solution with +/- 1 mM MgCl2 and then allowed to 
incubate in this solution for 3 hours at 37 °C under 5% CO2 95% air. At the end of 
treatment, cells were washed gently with 3 x 1.5 ml ofMEM at 37 °C, and then media was 
replaced with maintenance feed and treated cultures were left undisturbed for specified time 
points post-treatment. 
Isolation of poly-(A)+ RNA from hippocampal neuronal cultures: 
At specified times after experimental manipulations, hippocampal neuronal cultures 
were taken and poly-(A)+ RNA was isolated using the Micro-FastTrack™ Kit (Invitrogen 
Corporation, San Diego, CA). Briefly, each 35 mm culture dish was rinsed with phosphate 
buffered saline and then harvested in 1.0 ml of lysis buffer containing RNAase/Protein 
degrader. Cells were aspirated off of the culture plate into lysis buffer using a 1.0 ml syringe 
with an 18G needle, and then transferred to a 1.7 ml microfuge tube. Three 35 mm plates 
were sequentially pooled into 1.0 ml oflysis buffer to maximize yield of mRNA. Lysates 
were then incubated at 45 °C for I 5-20 min in a shaking H20 bath to allow for digestion of 
proteins and ribonucleases. Lysates were then adjusted to a 0.5M NaCl concentration , 
mixed thoroughly, and DNA was sheared by passing lysates through a 1.0 ml syringe with 
a 18-20 gauge needle 3-4 times. One Oligo ( dT) cellulose tablet was added to each tube and 
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allowed to go into suspension by gently agitating microfuge tube. Once Oligo (dT) cellulose 
was in suspension, samples were placed on rotator for 20 min at room temperature to allow 
for maximum hybridization of poly-(A)+ RNA to Oligo ( dT). Samples were then centrifuged 
at 4,000 x g for 6 min in a micro centrifuge to pellet Oligo ( dT) cellulose. The supernatant 
was then aspirated off, and the pellet was washed by gently resuspending in 1.3 ml binding 
buffer. Oligo (dT) cellulose was then pelleted by centrifugation at 4,000 x g for 6 min .. 
Pellets were washed in binding buffer until supernatant was no longer cloudy (3-4 times). 
After last wash, Oligo (dT) cellulose was transferred in a 0.3 ml vol of binding buffer to a 
spin-column/microfuge tube assembly. The assembly was centrifuged for 10 sec at 5,000 
x g, and eluant was discarded. The Oligo (dT) column was washed by adding 0.8 ml of 
binding buffer and quick spinning micro centrifuge. This was repeated 3 times to ensure 
removal of DNA from column. Non-polyadenylated RNA was removed by re-suspending 
column in 0.2 ml oflow salt wash and spun down. Low salt wash was repeated once more. 
Oligo (dT) columns containing poly-(A)+ RNA were transferred to new rnicrofuge tubes. 
Poly-(A)+ RNA was eluted off the column by suspending cellulose in 0.1 ml of elution 
buffer and spun down in micro centrifuge. This was repeated to yield a 0.2 ml volume of 
elution buffer containing the poly-(A)+ RNA. Poly-(A)+ RNA was precipitated by adding 
10 µl of glycogen (supplied as 2 mg/ml), 30 µI of2 M Sodium Acetate and 600 µI of200 
proof ethanol, and stored at - 70 °C for a minimum of 16 hours. Poly-(A)+ RNA was then 
pelleted by spinning at 16000 x g for 30 min in a micro centrifuge at 4 °C. Supernatant was 
removed and pellets were washed with 70% ethanol and then re-centrifuged for 30 min. at 
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4 cc. Supernatant was removed, and pellets were dried in a speed-vac (Savant Instruments, 
Inc., Holbrook, NY). Poly-(A)+ RNA pellets were then re-suspended in 100 µI ofDEPC­
treated (RNAase-free) H20 and stored at - 70 cc until used. All reagents and materials used 
for poly-(A)+ RNA isolation were treated to be RNAase-free. Total RNA was isolated from 
adult rat brain using the guanidinium thiocyanate-phenol-chloroform method previously 
described (Chomczynski and Sacchi, 1987). 
Northern Blot and Slot Blot of Poly-(A)+ RNA onto Nitrocellulose: 
Northern blots were carried out by standard techniques (Maniatis et al., 1982a). 
Briefly, denatured poly-(A)+ RNA was electrophoresed through a formaldehyde-containing 
1.0% agarose gel. After electrophoresis, the gel was briefly rinsed in RNAase-free Hp and 
treated for transfer by hydrolyzing in 50 mM NaOH, l O mM NaCl for 45 min. The gel was 
neutralized in 100 mM Tris-Cl (pH 7.5) for 45 min and then soaked in 20X SSC for 60 min. 
The poly-(A)+ RNA was allowed to transfer for 12-16 hours onto BASS nitrocellulose 
membrane (Schleicher & Schuell, Keene, NH) by capillary elution. The Northern blot was 
briefly rinsed in 3X SSC and allowed to thoroughly air dry for 1-2 hours. The RNA blot was 
baked at socc under vacuum for 2 hours. Slot blots were prepared by vacuum filtration of 
denatured poly-(A)+ RNA onto BASS nitrocellulose membrane using the MINIFOLD® II 
slot-blot system (Schleicher & Schuell, Keene, NH). Slot blots were then soaked in 3X SSC 
for 5 min and allowed to air dry. The RNA slot blot was baked at socc under vacuum for 
2 hours. 
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Cloning of cDNAs for GABAA-receptor subunits: 
Synthesis of first strand cDNA from rat hippocampal RNA was carried out using 
reverse transcription. Briefly, reverse transcription reactions contained 500 T)g of RNA, 5.0 
mM MgCl2, IX PCR buffer, 1.0 mM dNTPs, 20 mM OTT, 0.5 µI RNasin and 1.0 µI 
SuperScript™ II Rnase H Reverse Transcriptase (Gibco BRL, Gaithersburg, MD) in a 10 µI 
volume. Prior to adding reverse transcriptase, samples were denatured by incubating at 70 °c 
for 10 min. Reactions were initiated by addition of the reverse transcriptase and then allowed 
to incubate at 42°C for 60 min. Twenty-five base synthetic oligonucleotide primers were 
constructed (Operon Technologies, Alameda, CA) against specific GABAA receptor subunits 
using published sequences available from the GCG (Genetics Computer Group, University 
of Wisconsin); al :  L08490 (Draguhn et al., 1990), a2: L08491 (Wisden et al., 1992), a5: 
L08494 (Pritchett and Seeburg, 1990), P2: X15467 (Ymer et al., 1989) and y2: L08497 
(Shivers et al., 1989). The selected regions of published cDNA sequences that were 
amplified for each receptor subunit were: al (1013- 1645), a2 (1269-1529), a5 (1219-1749), 
p2 ( I  276-1840), and y2 (1185-1604). PCR amplification was carried out in a PTC-100™ 
programable thermal controller (MJ Research, Inc., Watertown, MA); reactions contained 
5 µM each of upstream and downstream primers, 1 mM dNTPs, IX PCR buffer, 2.5 mM 
MgC12 , cDNA from reverse transcribed hippocampal RNA and 1 unit of Taq polymerase 
(Promega, Madison, WI) in a final volume of 50 µI. Amplified products were checked by 
electrophoresis on 2.0% agarose gel and ethidium bromide stained to confirm presence and 
expected size of cDNA. PCR products were then cloned using the Original TA Cloning® Kit 
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(Invitrogen®, San Diego, CA). Briefly, I: I, I: I 0, I: I 00 dilutions of confirmed inserts were 
ligated into pCR™ 2.1 vector at 14 °C overnight. Ligation reactions included (in µl): 1.0 
diluted PCR product, 1.0 !OX ligation buffer, 2.0 pCR™ 2.1 vector (2511g!µl), 6.0 sterile 
H20, 1.0 T4 DNA ligase (4.0 Weiss units). Ligated products were transformed into One 
Shot™ cells (INV aF'). Competent cells (50 µI/vial) were treated with 2.0 µl of SM P-ME 
by stirring in with pipet tip. Two microliters ofligation reaction were added to competent 
cells and mixed gently. Cells were incubated on ice for 30 minutes, heat shocked for 30 
seconds in a 42 °C Hp bath and placed back on ice for 2 minutes. 450 µI of SOC medium 
was added to each vial and incubated for 1 hour at 37°C in a rotary shaker (225 rpm). Fifty 
µI and 200 µI of each transformation was spread onto LB agar plates containing 50 µg/ml 
ampicillin and previously treated with 40 µIX-Gal (40 mg/ml). Plates were incubated at 
37°C inverted for a minimum of 18 hours. Ten white colonies were selected from each plate 
and grown overnight in 2 ml of LB broth containing 50 µg/ml ampicillin at 37°C. A volume 
of 1.5 ml of the each cell suspension was utilized for mini plasmid DNA preparations carried 
out by alkaline lysis technique as previously described (Maniatis et al., 1982b ), restriction 
enzyme digested and run out on 2.0% agarose gel to confirm presence and size of insert. 
Once presence of insert was confirmed, large scale plasmid preparations were carried out and 
DNA was isolated using the cesium chloride extraction technique (Virginia Commonwealth 
University/Medical College of Virginia - Microbiology Core Facility) 
Sequencing of cDNAs: 
Sequencing of cDNAs was performed using the protocol for di-deoxy chain-
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terminating reactions from previously established techniques (Sanger et al., 1977). Briefly, 
plasmid DNA was denatured by NaOH followed by ethanol precipitation. GABAA receptor 
cDNAs were added with either Ml3 reverse or forward primers. This mixture underwent 
denaturation for 2 min at 65°C and then cooled slowly to allow for proper annealing of 
primers. Labeling reactions were initiated by the addition of labeling mix containing dNTPs, 
Sequenase T7 polymerase (United States Biochemical, Cleveland, OH) and [35S]-o:-dATP 
(DuPont-NEN, Boston, MA) to the annealed DNA mixture and incubated at room 
temperature for 5 min. Four equal aliquots of labeling reaction were added to four tubes each 
containing different terminating di-deoxy nucleotides (ddTTP, ddGTP, ddA TP and ddCTP) 
and the reactions were allowed to continue for l O min at 3 7 ° C. Reactions were then stopped 
with the addition of stop solution. Labeled samples were denatured at 90 °C for 2 min and 
immediately electrophoresed on a denaturing urea sequencing gel. Sequencing gels were 
dried and exposed to X-OMAT x-ray film (Kodak, Rochester, NY) for autoradiographic 
visualization. Sequences were read by hand and compared to published sequences from the 
GCG (Genetics Computer Group, University of Wisconsin) for conformation of correct 
cDNA insert. 
Radiolabeling of DNA Probes: 
cDNA probes were radiolabeled using the Random Primers DNA Labeling System 
(Life Technologies, Gaithersburg, MD). Briefly, 25-50 µg of cDNA was dissolved in 20 µI 
of dH20 and denatured by heating for 5 min in a boiling water bath and then immediately 
cooled on ice. 2 µl each of0.5 mM dGTP and 0.5 mM dTTP, 15 µl Random Primers Buffer, 
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5 µl each of [a-32P]dCTP and [a-32P]dATP (3000 Ci/mMOL,DuPont-NEN, Boston, MA) 
was added. The labeling reaction was initiated by the addition of I µl Kienow fragment (3 
units/µ!) and incubated at 25°C for I hour. Radiolabeled probes were purified using the TE 
MIDI Select®-D, G-50 micro-centrifuge spin columns (5 Prime-+3 Prime, Inc.®, Boulder, 
CO). Poly d(T) oligonucleotide was end-radiolabeled with (32P]-y-ATP (DuPont-NEN, 
Boston, MA) using T4 polynucleotide kinase (Gibco BRL, Gaithersburg, MD). Labelled 
probe was purified using the TE MIDI Select®-D, G-25 micro-centrifuge spin columns (5 
Prime-+3 Prime, Inc.®). Specific activity was determined for all radiolabeled probes by 
counting 1.0 µI of purified probe on a Beckman LS 6500 scintillation counter (Beckman 
Instruments Inc., Fullerton, CA). 
Hybridization Analysis of RNA Blots: 
RNA blots were prehybridized at 42°C for 12-16 hours in hybridization solution 
containing: 50 mM NaH2P04, 3X SSC, 5X Dendhardt's, 50% deionized formamide, 200 
µg/ml tRNA and I% salmon testes DNA. Hybridization with the specific GABAA subunit 
cDNA probes was carried out by adding 1-2 x I 06 CPM ( counts per minute) of radio labeled 
probe/ml of hybridization solution and allowed to incubate at 42°C for 12-16 hours in a 
shaking HzO bath. After hybridization, RNA blots were washed 3 x 10 min at 60°C in a IX 
SSC, 0.1 % sodium dodecyl sulfate (SDS) solution. For the poly d(T) oligonucleotide 
hybridization, 1-2 x 106 CPM of radiolabeled probe was added per ml of hybridization 
solution containing: 5X Denhardt's, 5X SSPE, 200 µg/ml tRNA, 0.5% SDS and 15% 
deionized formamide. Poly d(T) oligonucleotide hybridized blots were washed 3 x 5 min at 
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37°C in a 2X SSC, 1.0% SDS solution. Washed blots were then exposed to either X-Omat 
film (Kodak, Rochester, NY) or a phosphor screen (Molecular Dynamics, Sunnyvale, CA) 
for varying durations to acquire correct exposure. Phosphor screens were scanned on a 
Phosphor lmager and hybridization signal was analyzed using lmageQuant software 
(Molecular Dynamics, Sunnyvale, CA). 
GABAA a2 Antisense Oligonucleotide Knockdown Analysis: 
Antisense and missense oligonucleotide probes were constructed (Operon 
Technologies Inc., Alameda, CA). For the GABAA a2 knockdown, an antisense 
oligonucleotide complementary to the + 1 to + 18 nucleotides was constructed with the 
following sequence: 5' CAA CCT GGC TGG GTC CAC 3'; missense GABAA a2 sequence 
was as follows: 5' CAA CCG TCG TGG GTC CAC 3'. Hippocampal neuronal cultures were 
treated for 5 days with 1.0 µM of either antisense or missense oligonucleotides every 24 
hours. During the treatment regimen, hippocampal cultures were maintained in N3 
supplement containing 20% conditioned media at 37°C under 5% CO2 95% air. At the end 
of the 5 day treatment protocol, cultures were utilized for electrophysiological analysis. 
GABAA Receptor p Subunit Immunoreactivity: 
Four to six micrograms of balanced proteins were blotted onto Trans-Blot® 
nitrocellulose membrane (Bio-Rad, Hercules,CA) under vacuum filtration using a PR 600 
slot blot apparatus (Hoefer Scientific Instruments, San Francisco, CA). Antibody blot 
analysis was carried out using a Vectastain® ABC alkaline phosphatase staining kit (Vector 
Laboratories, Burlingame, CA). Briefly, protein blots were incubated overnight at 4 °C on 
37 
a rotary shaker in a PBS-blocking solution containing: 5.0% dry milk (w/v), 0.05% TWEEN-
20 and 0.0 I% anti-foam. Blots were then incubated in PBS-blocking solution containing a 
primary antibody specific for the GABAA receptor� chain (monoclonal lgG, clone bd 17: 
Boehringer Mannheim Biochemica, Indianapolis, IN) for I hour on rotary shaker at room 
temperature. Unbound antibody was removed by 3 washes in PBS-blocking solution. Blots 
were then incubated with a biotinylated secondary antibody in PBS-blocking solution for 30 
min at room temperature. Excess secondary antibody was removed by 3 washes with PBS. 
Labelled proteins were reacted with a peroxidase substrate solution and allowed to develop. 
The staining reaction was stopped by washing in several changes of dH20. Developed 
membranes were allowed to air dry, digitized using a HP ScanJet 4C/T high resolution 
scanner (Hewlett Packard, Boise, ID) and intensity measurements were obtained using a 
computer-assisted densitometer (Mocha0, Jandel Corp., San Rafael, CA). 
Photoaffinity Labeling of [3H)-Flunitrazepam to Hippocampal Culture Membranes: 
Photoaffinity labeling of the BZ receptors was carried out by modification of methods 
previously described (Bowling and DeLorenzo, 1987; Mohler et al., 1980). Three days 
following low Mg++ treatment, hippocampal neurons were washed twice with exposure 
solution(+ 1.0 mM MgC12) at 37°C. The wash solution was rapidly replaced with ice-cold 
homogenization buffer containing: 50 mM Tris-Citrate (pH 7.2) and 0.32 M sucrose and the 
cells were immediately scraped from the culture dish surface. The cell suspension was 
transferred into a glass homogenizer (Kontes, Vineland, NJ), and disrupted with IO strokes 
of the homogenizer. To obtain a crude P-2 membrane preparation, homogenates were 
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centrifuged at 18000 x g for 30 min. Membrane fractions were washed three times in 50 mM 
Tris-Citrate buffer (pH 7.2). Washed membrane preparations were normalized for protein 
using a micro-Bradford reagent system (Bio-Rad, Hercules,CA). Saturation flunitrazeparn 
(FNZ) binding reactions were carried out as previously described (Bowling and DeLorenzo, 
1987; Mohler et al., 1980). Briefly, reaction volumes of 100 µI contained P-2 protein (15 µg) 
and 40 11M [3H]-FNZ (85 Ci/mMOL, DuPont-NEN, Boston, MA) ± 40 µM cold FNZ. 
Reactions were allowed to reach equilibrium at 4 °C for 2 hours. The FNZ was covalently 
bound to P-2 membrane by exposure to UV light (1500 µ W/cm2/sec; UVP Products, Upland, 
CA) at 4 °C for 30 min. Photoaffinity labeled membrane proteins were resolved by SDS­
p AGE. The SDS-P AGE gel was Coomassie stained and sliced in mm fractions from the 
origin to the dye front. Gel slices were digested in HP2, INSTA-GEL® XF scintillation 
fluid (Packard, Meridan, CT) was added and the [3H]-FNZ per slice was quantitated on a 
Beckman LS 6500 scintillation counter (Beckman Instruments Inc., Fullerton, CA). A major 
peak of [3H)-FNZ binding was observed in association with the 50 kDa a GABA A receptor 
protein as described previously (Mohler et al., 1980) and specific binding was determined 
by subtracting non-specific ([3H]-FNZ + cold FNZ) from total binding ([3H)-FNZ alone) in 
the 50 kDa a subunit peak. 
Electrophysiological Analysis of SRS Activity in Hippo cam pal Neuronal Cultures: 
Electrophysiological analysis was performed using previously established procedures 
in our laboratory (Coulter et al., 1992; Sombati et al., 1991). Briefly, cell culture media was 
replaced with recording solution containing (in mM) 145 NaCl, 2.5 KC!, 10 HEPES, I 
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MgC12, 2 CaC12, 10 glucose, .002 glycine, pH 7.3 and osmolarity adjusted to 325 mOsm with 
sucrose. Cultures were then mounted on the stage of an inverted microcsope (Nikon 
Diaphot, Japan), continuously perfused with recording solution and then studied using the 
whole cell current-clamp recording procedure. Patch electrodes with a resistance of 2-4 MQ 
were pulled on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, CA) 
and then fire polished. For whole-cell current-clamp analysis, the electrode was filled with 
a solution containing (in mM) 140 K+gluconate , I MgC12 and 10 Na-HEPES, ph 7.2, 
osmolarity adjusted to 3 10 ± 5 mOsm with sucrose. Data was digitized and transferred to 
video tape using a PCM device (Instrutech, Mineola, NY; 18 kHz sampling frequency) and 
then played back on a DC-500 Hz chart recorder (Astro-Med Dash II, Warwick, RI). 
Intracellular recordings were carried out using a Axopatch ID amplifier (Axon Instruments, 
Foster City, CA) in whole-cell current-clamp mode. 
Electrophysiological Analysis of IPSC Amplitudes: 
For electrophysiological analysis of spontaneous inhibitory postsynaptic current 
(IPSC) amplitude, voltage-clamp recordings were performed using procedures similar to 
what was utilized by Soltesz et al. (Soltesz et al., 1995). Briefly, culture medium was 
changed to recording solution containing (in mM) I tetrodotoxin (TIX), 25 APV and I 0 
CNQX, 145 NaCl, 2.5 KCl, 10 HEPES, 1 MgCl2, 2 CaCl2, 10 glucose, .002 glycine, pH 7.3 
and osmolarity adjusted to 325 mOsm with sucrose. Patch electrodes with a resistance of2-4 
MQ were pulled on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, 
CA) and then fire polished. The pipet solution contained (in mM) 140 CsCI, 1 MgC12, 10 
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HEPES, I. I ethylenebis(oxyethylenenitrilo) tetra acetic acid (EGTA) and adjusted to pH 7.2 
with CsOH and 310 mOsm with sucrose. After the patch-clamp was established on a 
pyramidal neuron, the membrane potential was clamped at -50 mV and voltage-clamp 
recording mode was employed using an Axopatch ID amplifier (Axon Instruments, Foster 
City, CA). Data was digitized and transferred to video tape using a PCM device (Instrutech, 
Mineola, NY; 18 kHz sampling frequency) and then played back on a DC-500 Hz chart 
recorder (Astro-Med Dash II, Warwick, RI). To evaluate the IPSCs, digitization analysis and 
detection of individual mIPSCs were done using the Strathclyde Electrophysiology Software 
WCP V 1.2 (Dagan Corporation, Minneapolis, MN) and IPSC amplitudes and frequencies 
were determined .. 
C. RESULTS: 
Whole-cell current-clamp analysis was carried out on low Mg++ and sham treated 
hippocampal cell cultures at selected time intervals following the treatment protocol. 
Electrophysiological analysis of control pyramidal neurons revealed normal activity 
exhibited by the presence of spontaneous excitatory postsynaptic potentials (EPSPs ), and the 
generation of occasional action potentials (Fig. IA). Following low Mg++_treatment, 
hippocampal cultures displayed an enduring "epileptic" alteration evidenced by spontaneous 
recurrent seizure bursts (Fig. lB), that have previously been shown to range in duration from 
20 sec to 2 min with a resting membrane potential of neurons ranging between -50 to -65 m V 
(Sombati and DeLorenzo, 1995). Further expansion of one of the "epileptic" bursts revealed 
the presence of individual PDSs. Even further expansion revealed the complexity of the 
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individual PDSs with a spike frequency discharge of approximately 1 7 Hz. The expression 
of this hyperexcitable state was a permanent alteration in these neuronal cultures in that the 
SRS activity has been shown to persist for the life of the culture (Sombati and DeLorenzo, 
1995). 
To determine if low Mg++ treatment and subsequent induction of SRSs in 
hippocampal neuronal cultures resulted in alterations in cellular density and morphology, 
photomicrographs were obtained from the same field of neurons in culture at different 
intervals during the treatment protocol. Prior to low Mg++ treatment, neuronal morphology 
was characterized by a extensive network of dendritic processes and presence of defined 
neuronal somata (Fig. 2A). Photomicrographs obtained from neuronal cultures one day (Fig. 
2B) and three days (Fig. 2C) post low Mg++ exposure demonstrated no gross alterations in 
neuronal culture morphology or density in association with the SRSs evident in this model. 
Other work from this laboratory demonstrated that low Mg++ treatment resulted in a modest 
decrease of 6.8% in cell counts compared to control 2 days following induction of SRSs 
(Gibbs et al., 1997b). These findings demonstrated that there were no gross changes in 
neuronal culture morphology or density associated with the "epileptic" condition observed 
in this model. 
Sequence analysis by the di-deoxy chain-termination method (Sanger et al., 1977) 
demonstrated that the cDNA clones constructed for the al, a2, a5, �2 and y2 subunits of the 
GABAA receptor had the correct sequences as compared to those published in the GCG 
(Genetics Computer Group, University of Wisconsin). 
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To determine specificity of the cDNA clones constructed to the al , a2, a5, p2, and 
y2 GABAA receptor subunits, random primer labeling of cDNA probes and subsequent 
hybridization analysis using poly(A)+ RNA Northerns was carried out (Fig. 3). Stringency 
conditions were determined to achieve specificity of the hybridized signal. Hybridization 
with the al cDNA probe revealed a single mRNA transcript with a length of approximately 
4.0 kb (kilobases). Other studies have demonstrated the existence of two separate bands in 
close apposition to each other at approximately 3.8 and 4.3 kb (Khrestchatisky et al., 1989). 
Our finding of only one band is probably attributed to lower resolution of resolving the 
mRNA samples out on the agarose gel. Two mRNAs were detected with sizes of3.6 and 6.6 
kb when Northern blots were probed with the cDNA specific for the GABAA a2 subunit. 
These findings agreed with a previous study performed by Khrestchatisky et al. (1991). A 
single mRNA species 2.8 kb in size was detected using the a5 subunit cDNA probe which 
agrees with established findings (Pritchett and Seeburg, 1990). Single mRNAs were detected 
at 8.0 and 4.2 kb for the p2, and y2 cDNAs respectively. 
To evaluate changes in mRNA levels for the GABAA receptor subunits associated 
with this model ofSRS, Poly(A)+ RNA was isolated from control and "epileptic" cultures 
at various time intervals, and hybridization blot analysis was carried out using the selective 
cDNA probes complementary to the GABAA receptor subunits. Oligo-d(T) hybridization 
was used to normalize for poly-(A)+ RNA loadings. One day following the induction of the 
SRSs in the neuronal cultures, a significant decrease in mRNA levels of 20.2±3.1 % (p = 
0.04, low Mg++: n = 9, sham: n = 14) and 36.7±8.9% (p = 0.05, n = 3) for GABAA a2 and a5 
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receptor subunits respectively was observed (Fig. 4). Hybridization analysis of the GABAA 
a 1, p2, and y2 subunits revealed no significant changes in expression levels at the one day 
time point. 1bree days following low-Mf+ treatment of neuronal cultures, transcript levels 
for the a5 receptor subunit remained significantly decreased by 14.5±3.6% (p = 0.04, low 
Mg++: n = 7, sham: n = 8) of control, while a2 returned to basal levels. P2 mRNA 
expression remained at control levels at the 3 day time point (Fig. 5). 
A number of modulatory sites on the GABAA receptor complex have been 
determined, one of which binds the BZs. The action of BZs on this site act to modulate 
GABAA receptor function to produce a number ofneurophysiological effects which include 
anxiolytic, antiepileptic, and muscle relaxant. The binding ofBZs has been shown to occur 
on the a subunit of the receptor channel, and its affinity for binding selective BZs is 
dependent on which member of this class of GABAA receptor subunits is present (Pritchett 
et al., 1989). We have employed the technique of photoaffinity labeling of [3H]­
flunitrazepam (Mohler et al., 1980) to evaluate levels of the 50 kDa a subunit protein in 
membranes preparations from control and "epileptic" neuronal cultures 3 days following 
induction of SRSs. Irreversible photoaffinity labeling of [3H]-flunitrazepam was carried out, 
and reaction proteins were resolved by SDS-PAGE electrophoresis and binding to the 50 kDa 
protein was analyzed. A significant decrease of 62.8±3.24% (p = 0.00016, n = 3) in BZ 
binding was observed in membranes isolated form "epileptic" neuronal cultures when 
compared to sham treated control values (Fig 6). 
The use of antisense oligonucleotides to study the function of individual proteins by 
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their selective suppression has recently been established and accepted throughout the 
scientific community (Pilowsky et al., 1994). The mechanism by which the complementary 
antisense oligonucleotide produces a decrease in expression of the target protein is via 
hybridization to the specific mRN A transcript and blockade of its translation. We wanted 
to determine if the reductions in GABAA receptor subunit mRNA levels observed in this 
model are involved in the elicitation of SRSs. To address this question, we constructed an 
antisense oligonucleotide probe to the GABA A a:2 receptor subunit to selectively suppress 
(knock-down) this protein. Electrophysiological analysis of hippocampal cultures treated 
with antisense oligonucleotides specific for the a:2 subunit using the voltage-clamp recording 
technique revealed a dramatic reduction in amplitude oflPSCs (Fig. 7 A). Quantification of 
this analysis demonstrated that a:2 subunit suppression resulted in a significant decrease of 
43.3±4.8% (p = 0.00003, antisense: n = 5, missense: n = 6) in IPSC amplitude compared to 
missense controls (Fig. 7B). Previous work from our lab has demonstrated that "knock­
down" of GABAA a:2 also resulted in a profound state of neuronal hyperexcitability in 
hippocampal cultures (Sombati et al., 1995). 
To assess if the decrease in GABAA receptor function observed in this model of SRSs 
is the result of a general reduction in receptor protein expression, a monoclonal antibody 
specific for the p subunit family of the receptor was employed. Given that most all GABAA 
receptors contain at least one p subunit would indicate that their expression level would 
reflect that of the whole receptor complex. Homogenates were prepared from control and 
low-Mg++ treated hippocampal neuronal cultures at different time intervals post-treatment 
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and blotted onto nitrocellulose for immunostaining. Induction of the "epileptic" condition 
in these neuronal cultures resulted in no significant change in GABA
A 
p subunit antibody 
staining immediately following low Mg++ treatment (Fig. 8) or 24 hours post-treatment (Fig. 
9). 
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Figure 1. Induction of spontaneous recurrent seizures in hippocamapal neuronal 
cultures. Intracellular recordings were carried out in whole-cell current-clamp mode on 
sham and low Mg++ treated hippocampal neuronal cultures following treatment. 
A. Electrophysiological analysis of control neurons revealed "normal" baseline 
recordings the with occasional generation of spontaneously occurring action potentials. 
B. Intracellular recording from an "epileptic" neuron after low Mg++ treatment exhibiting 
4 separate seizure discharges. Expansion of one of the seizure bursts displays the 
presence of individual PDSs. Further expansion of a 10 sec interval reveals the 
complexity of the individual PDSs which display a distinct beginning and termination 
with a spike frequency of approximately 17 Hz. 
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Figure 2. Photomicrographs of hippocampal neuronal cultures were obtained from the 
same field at different intervals during the treatment protocol. A, Pre-treatment. B, 24 hours 
post-low Mg++. C, Three days post-low Mg++ . (Scale Bar = 100 µm). 
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Figure 3. Northern blots were probed with selective cDNAs constructed to GABAA 
receptor subunits, and stringency conditions were determined for specific hybridization 
analysis. Poly (A)+ hippocarnpal RNA Northerns were employed for GABAA al, a2, 
and a5 cDNA hybridizaiton. Total RNA Northerns were used for GABAA p2 and y2 
cDNA hybridization analysis. Numbers denote the size in kilobases (Kb) of detected 
mRNA transcripts. 
51 
a1 a2 a5 �2 y2 
8.0 
4.0- 4.2-
Figure 4. Poly-(A) + RNA slot hybridization analysis of GABAA receptor subunit 
expression in hippocampal neuronal cultures 24 hours following induction of 
spontaneous recurrent seizure activity. Data are expressed as the mean± SEM. *, p � 
0.05, Student's t-test. 
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Figure 5. Poly-(A)+ RNA slot hybridization analysis ofGABAA receptor subunit 
expression in hippocampal neuronal cultures 3 days following induction of spontaneous 
recurrent seizure activity. Data are expressed as the mean± SEM. * ,p = 0.04, Student's 
t-test. 
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Figure 6. Quantification of irreversible photoaffinity labelling of [3H]-flunitrazepam 
to the approximately 50 kilodalton (kDa) a subunit of the GABAA receptor in membranes 
isolated from control and low Mg++ hippocampal cultures 3 days following treatment (see 
methods). Data are expressed as the mean± SEM (n = 3, each}. * ,P = 0.00016, 
Student's t-test. 
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Figure 7. Voltage-clamp analysis ofhippocampal cultures treated with missense 
( control) and antisense oligonucleotide probes constructed against the GABAA cx2 
receptor subunit. A. Representative voltage-clamp recordings of spontaneous inhibitory 
postsynaptic currents (IPSCs) from hippocampal cultures following 5 days of treatment 
with antisense or missense (1 µM) oligonucleotides. B. Quantification of (IPSC) 
amplitude from hippocampal neuronal cultures treated with GABAA cx2 antisense. Data 
are expressed as the percent mean± SEM of control (missense) (missense: n = 6, 
antisense: n = 5). *,p = 0.00003, Student's t-test. 
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Figure 8. Protein blot analysis of homogenates from control and low Mg++ 
hippocampal neuronal cultures immediately following low Mg* treatment. A. Antibody 
staining of control and low Mg++ hippocampal neuronal culture protein blots using a 
mAB specific for the � subunits of the GABAA receptor (see methods). 
B. Quantification of GABAA � subunit antibody staining in control and low Mg* 
cultures immediately following treatment. Data are expressed as the mean± SEM (n = 5, 
each). 
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Figure 9. Protein blot analysis of homogenates from control and low Mg+-1-
hippocampal neuronal cultures 24 hours post treatment. A. Antibody staining of control 
and low Mg++ hippocampal neuronal culture protein blots using a mAB specific for the p 
subunits of the GABAA receptor (see methods). B. Quantification ofGABAA P subunit 
antibody staining in control and low Mg++ cultures 24 hours post treatment. Data are 
expressed as the mean ± SEM (n = 5, each). 
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D. DISCUSSION: 
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The data presented demonstrate that long-lasting alterations in GABAA receptor 
expression are associated with the enduring enhancement of neuronal excitability that ensues 
in the hippocampal neuronal culture model of epilepsy. Treatment of primary hippocampal 
neuronal cultures with a Mg++-free media for 3 hours results in the induction of an long-lived 
"epileptic" condition reflected by the expression of spontaneous recurrent seizure discharges 
for the life of the culture (Fig. 1 ). The seizure phenomena displayed in these neuronal 
cultures have been shown to exhibit characteristics similar to what is observed in intact 
models of epilepsy, thus underscoring the potential this in vitro model offers towards 
understanding the molecular mechanisms that underlie this condition (Sombati and 
DeLorenzo, 1995). 
Changes in GABAergic inhibitory processes have been shown to occur with seizures 
and epilepsy, and can arise at several levels within the inhibitory pathway (Dudek and Spitz, 
1997; Kapur et al., 1989; Lothrnan et al., 1991). Researchers have hypothesized that a 
selective loss of excitatory innervation onto inhibitory intemeurons contributes to the 
underlying mechanisms of epileptogenesis associated with temporal lobe epilepsy (Dudek 
and Spitz, 1997). This would suggest that the inhibitory machinery remains intact, and that 
preceding mechanisms have been arrested. Suppression of GABAergic inhibitory function 
at the postsynaptic membrane has also been intensely studied in different models of seizures 
and epilepsy (Buhl et al., 1996; Friedman et al., 1994; Gibbs et al., 1997b; Gibbs et al., 
1997a; Isokawa, 1996; Kapur and Macdonald, 1997; Merlin and Wong, 1993; Rice et al., 
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1996). The findings from these investigations show that lasting alterations in GABAA 
receptor function occur with seizures and epilepsy. Elucidation of the molecular mechanisms 
which underlie these maladaptive changes in GABAA receptor function would most certainly 
bring us closer to a better understanding of epileptogenesis. 
The heterogeneity in GABAA receptor function observed throughout the CNS has 
been proposed to be the result of diverse receptor subunit combinations (McKernan and 
Whiting, 1996). It is believed that this diversity in subunit makeup of GABAA receptors is 
essential to the overall maintenance of inhibitory mechanisms in the brain. Several 
investigations have demonstrated that the presence of selected subunits are essential for 
GABAA receptor sorting and assembly. In a mouse strain that is homozygous for a 
chromosomal deletion spanning the GABAA cx5 gene, researchers found a deficit in 
formation of a subclass of GABAA receptors with paralleled decreases in P2/3 and y2 
immunoreactivity in the hippocampus (Fritschy et al., 1997). Selected GABAA subunits have 
been shown to control the cellular localization and sorting of the receptor complex in 
polarized cells (Perez-Velazquez and Angelides, 1993). In consideration of these findings, 
one could postulate that abnormal expression in receptor subunits could evoke 
maladaptations in GABAergic processes, thus resulting in a decrement of inhibitory drive. 
We have demonstrated a selective and long-lasting decrease in GABAA ex subunit mRNA 
expression in association with the induction of the "epileptic" condition in hippocampal 
neuronal cultures (Fig. 4 and 5). These findings are in agreement with published results from 
both in vitro (Vick et al., 1996) and in vivo (Rice et al., 1996; Houser et al., 1995) models 
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of epilepsy. 
The GABAA receptor contains a number of both positive and negative modulatory 
sites that are intrinsic to its physiological function (Barnard et al., 1987). The action of 
benzodiazepines (BZs) on the GABAA receptor complex is one such allosteric mechanism, 
and has been shown to occur through binding to the a; subunit (Burt and Karnatchi, 1991 ). 
Decreased BZ receptor binding has been observed in association with both human epilepsy 
(Savic et al., 1988), and in animal models of seizures and epilepsy (Kapur et al., 1994; Kapur 
and Macdonald, 1997). Irreversible saturating benzodiazepine binding to the GABAA 
receptor complex is an established method for the quantitation of a; subunit protein levels 
(Bowling and DeLorenzo, 1987). We have demonstrated that induction of SRSs in 
hippocarnpal neuronal cultures results in a significant decrease in [3HJ-flunitrazeparn binding 
to the 50 kDa a; subunit of the GABAA receptor (Fig. 6). These findings are further 
substantiated by other work carried out with this model showing a significant and long­
lasting decrease in the efficacy of clonazeparn augmentation of GABAA receptor response 
in association with the "epileptic" condition evidenced in these hippocarnpal cultures (Gibbs 
et al., 1997b ). 
Whether decreases in GABAA a; subunit mRNA expression and protein levels are 
directly involved in the development of the "epileptic" condition observed in this model, or 
rather a result of seizure discharges is unclear. To address this question, we utilized 
antisense oligonucleotide technology to selectively suppress GABAA a:2 expression in 
hippocarnpal neuronal cultures. We demonstrated a significant decrease in IPSC amplitude 
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in hippocampal cultures treated with the GABAA ex2 antisense oligonucleotide (Fig. 7 A and 
B). In addition, previous data from this laboratory has demonstrated that GABAA ex2 
antisense "knock-down" treatment ofhippocampal cultures results in a profound increase of 
neuronal excitability (Sombati et al., 1995). This data suggests that a selective suppression 
of GABAA ex subunit expression can incur alterations in receptor function resulting in 
attenuation of inhibitory response. 
It has previously been shown the low Mg++ treatment of hippocampal neuronal 
cultures and subsequent induction of SRSs resulted in a significant reduction of GABAA 
receptor current density (Gibbs et al., 1997b). Recombinant GABAA receptor studies have 
demonstrated that both ex and P subunits confer changes in affinity for GABA binding to the 
receptor complex (Levitan et al., 1988; Ymer et al., 1989). To determine if changes in 
expression for the P class of receptor subunits are associated with the "epileptic" condition 
of this culture model, we carried out protein staining with a GABAA p subunit specific 
antisera. No change in protein levels for the p class of the GABAA receptor subunits was 
observed in association with the induction of SRSs in hippocampal neuronal cultures ( Fig. 
8). This data further suggests that selective changes in GABA A ex subunit expression occur 
in association with the altered state of neuronal excitability evidenced in the hippocampal 
neuronal culture model of epilepsy. 
Results of this study demonstrate for the first time a direct association between 
GABA A receptor subunit expression and induction ofSRS activity in an in vitro hippocampal 
culture model of epilepsy. Furthermore, this study demonstrates that selective suppression 
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of GABAA ex subunit expression can result in a reduction of GABAergic inhibitory response 
in hippocarnpal neuronal cultures. The pathogenesis of epilepsy is very complex and is 
believed to involve multiple mechanisms. Our data indicate that long-lasting decreased 
GABAA subunit gene expression may underlie mechanisms involved in the emergence and 
maintenance of some forms of seizures and epilepsy. 
DECREASE IN MULTIFUNCTIONAL Ca++/CALMODULIN-DEPENDENT 
PROTEIN KINASE II ACTIVITY IN A HIPPOCAMPAL CELL CULTURE 
MODEL OF RECURRENT SPONTANEOUS SEIZURE 
A. INTRODUCTION: 
The neuropathological condition of epilepsy, a chronic disease associated with 
recurrent seizure discharge, affects approximately 1 % of the population (Hauser and 
Hesdorffer, 1990). Seizures occur when there is a loss in the ability of the central nervous 
system to regulate neuronal activity resulting in the synchronous and uncontrollable firing 
of a population of neurons (Lothman et al., 1991). Although there are a number of 
phannacological interventions that successfully manage the seizure episodes associated with 
epilepsy, the cellular and molecular mechanisms that underlie these neuropathological 
manifestations still remain unclear. A substantial amount of evidence suggests that the 
primary mechanisms involved in the elicitation of seizures are due to either a suppression of 
inhibitory synaptic transmission or enhancement of excitatory synaptic pathways. Although 
changes in these two systems, either independently or in concert with each other, demonstrate 
a clear relevance in seizure generation at the functional level, the multitude of the underlying 
regulatory pathways involved in sustaining the epileptogenic phenotype are very complex. 
The Ca++ ion is a major second messenger in the central nervous system. Increases 
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in intracellular ca++ concentration have been shown to be involved in regulating a wide range 
of cellular events including neurotransmitter release, cell survival, dendritic sprouting, and 
learning and memory (Bading et al., 1993). The Ca++ signal is transduced via biochemical 
regulation of many intracellular proteins some of which include kinases, phosphatases, 
proteases and transcription factors. The Ca++ /calmodulin-dependent kinase II enzyme (CaM 
Kinase 11) is a major protein kinase that is highly enriched in the brain, constituting 0.5-1.0% 
of total brain protein, and up to 2% of hippocampal protein (Erondu and Kennedy, 1985). 
Phosphorylation of a multitude of substrates by CaM kinase II enables its modulation of 
many cellular processes including neurotransmitter biosynthesis and release, cytoskeletal 
structure, ligand-gated and calcium-dependent ion channels, and transcriptional regulation 
(Churn, 1995). Furthermore, activation of CaM kinase II has also been shown to play a role 
in forms of learning and memory, such as in the model of long-term potentiation (LTP) 
(Soderling, 1993). The findings presented above clearly establish the importance of CaM 
kinase II in maintaining normal physiological processes throughout the CNS. Alterations in 
activity of this enzyme system would be expected to precipitate pathological consequences. 
There appears to be a delicate balance in the role that CaM kinase II plays between 
physiological and pathological processes that occur in neuronal cells. A change in activity 
of CaM kinase II has been associated with a number of neuropathological models which 
include stroke (Churn et al., 1992b ), pilocarpine-induced TLE (Kochan et al., 1997), kindling 
(Goldenring et al., 1986; Wasterlain and Farber, 1984) status epilepticus (Bronstein et al., 
1988; Churn et al., 1991; Perlin et al., 1992; Wasterlain et al., 1992) and NMDA-dependent 
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excitotoxicity (Churn et al., 1995). 
An increasing amount of evidence suggests a role for alteration of CaM kinase II 
function with seizures and epilepsy. Transgenic mice carrying a null mutation(-/-) for a 
CaM kinase II have exhibited significant neuronal hyperexcitability and epileptic seizures 
arising from limbic structures (Butler et al., 1995). Perlin and colleagues (1992) 
demonstrated, using the rat SE model of continuous hippocampal stimulation, that expression 
of seizure discharges was associated with an inhibition of CaM kinase II activity, and that 
there was a direct correlation between intensity of seizure activity and degree of inhibition 
of the enzyme. Anderson et al. (1986) have shown that treatment of a rat hippocampal slice 
preparation with Mg++-free solution resulted in the expression of spontaneous ictal-like 
events which resemble tonic and clonic seizure discharges. Analysis of CaM kinase II in 
these slice preparations revealed a significant suppression in enzyme activity associated with 
the seizure-like events exhibited in this model (Churn et al., 1991 ). Using the kindling model 
of epilepsy, Goldenring et al. (1986) found a suppression of Ca++/calmodulin-dependent 
kinase activity in hippocampal membrane preparations isolated from kindled brain. These 
findings are further substantiated by work from other laboratories demonstrating a kindling­
induced alteration in CaM kinase II function represented by decreases in activity (Wasterlain 
and Farber, 1984), irnmunoreactivity (Bronstein et al., 1990), and mRNA expression 
(Bronstein et al., 1992). In light of these findings, alterations in activity and expression of 
CaM kinase II have been shown to occur in models of seizures and epilepsy, and may 
contribute to the underlying mechanisms of the pathophysiology exhibited in these 
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conditions. 
We employed the hippocarnpal cell culture model of recurrent spontaneous seizure 
(Sombati and DeLorenzo, 1995) to study the effect of epileptogenesis on the activity of CaM 
kinase II in a hippocarnpal neuronal culture network. Treatment ofhippocampal cell cultures 
with a Mg++_free media for 3 hours results in the induction of an "epileptic" state as 
evidenced by the presence of spontaneous recurrent seizure (SRS) activity throughout the life 
of the neuronal culture. Decreasing Ca++ concentration to 0.2 mM or addition of 50 µM APV 
in the Mg++-free exposure media results in the blockade of the expression of SRSs, 
suggesting an NMDA receptor, Ca++ -dependent mechanism in the induction of the 
epileptogenic state in this model. This hippocampal neuronal culture model of epilepsy is 
a powerful tool for investigating the biochemical, biophysical and molecular mechanisms 
that underlie seizures and epilepsy in that it allows for easy manipulation and evaluation of 
the culture environment. 
B. METHODS: 
Primary Hippocampal Neuronal Cultures: 
Primary hippocampal cultures were prepared by a modification of the method of 
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from 
2-day postnatal Sprague-Dawley rat pups were dissected out from the brain and prepared for 
tissue culture by 0.25% trypsin digestion followed by trituration through a Pasteur pipet. 
Triturated cells were counted by cresyl violet blue exclusion analysis using a hemocytometer, 
and 2 x 1 O' cells were plated on a 35 mm dish previously coated with growth factor reduced 
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MATRIGEL® matrix (Collaborative Biochemical, Bedford, MA) to aid in the attachment 
of the hippocampal cells. One day following plating, cultures were treated with 5 µM 
cytosine arabinoside to inhibit further non-neuronal cellular proliferation. Hippocampal 
cultures were maintained in MEM containing N3 supplement media plus 20% conditioned 
media. The N3 supplement contained 25 mM HEPES buffer (pH 7.4), 2 mM glutamine, 5 
µg!ml Insulin, 100 µg/ml transferrin, l 00 µM putrescine, 30 T]M sodium selenite, 20 TJM 
progesterone, 1 mM sodium pyruvate, 0.1% ovalbumin, 20 T]g/ml T3, 40 T]g/ml 
corticosterone. Conditioned media was obtained from confluent hippocampal glia beds 
plated out at a density of 1.0 x 106 cells/75 cm2 flasks and maintained in MEM containing 
10% fetal bovine serum and 2 mM glutamine. Both hippocampal cell cultures and glia beds 
were maintained at 37°C under 5% CO2 95% air. 
Mg*-free Treatment ofHippocampal Cell Cultures: 
After two weeks in culture, maintenance media was replaced with exposure solution 
containing (in mM): 145 NaCl, 2.5 KC!, 10 HEPES, ±1 MgC12, 2 CaC12, 10 glucose, .002 
glycine, pH 7.3, and osmolarity adjusted to 325m0sm with sucrose. Cells were washed 
gently with 3 x 1.5 ml of exposure solution with ±1 mM MgCl2 and then allowed to incubate 
in this solution for 3 hours at 37°C under 5% CO2 95% air. In experiments for determining 
NMDA receptor-dependency, hippocampal cultures were treated with 25 µM D-APV for 20 
min prior to and during Mg++ -free exposure. At the end of treatment, cells were washed 
gently with 3 x 1.5 ml ofMEM at 37°C, and then media was replaced with maintenance feed 
and treated cultures were left undisturbed at 37°C under 5% CO2 95% air for specified time 
points post-treatment. 
CaM Kinase II Assay: 
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For quantitation ofCaM kinase II activity, hippocampal neurons were washed twice 
with recording solution at 37°C. The wash solution was rapidly replaced with ice-cold 
homogenization buffer containing 100 mM Tris-HCl (pH 7.4), 6 mM ethylenediamine-tetra 
acetic acid (EDT A), 6 mM EGTA, 0.3 mM phenylmethylsulphonyl fluoride (PMSF), and the 
cells were immediately scraped from the culture dish surface. The cell suspension was 
transferred into a glass homogenizer (Kontes, Vineland, NJ), and disrupted with IO strokes 
of the homogenizer. Homogenates were normalized for protein using a micro-Bradford 
reagent (Bio-Rad, Hercules,CA) and studied for endogenous calcium-dependent protein 
phosphorylation. Standard phosphorylation reaction solutions contained 10-12 µg protein, 
10 mM MgCl,, 0.2 mM EDTA, 7 µMy- ["P] ATP (10 ci/mMol, DuPont-NEN, Boston, 
MA), 10 mM Tris-HCI (pH 7.4), ±5 µM CaCl, and± I µg calmodulin. Standard reactions 
were performed in a shaking water bath at 30°C. Reactions were initiated by the addition 
of calcium, continued for 1 minute, and terminated by the addition of 5% SDS STOP 
solution. Proteins were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
and protein bands were visualized by silver-stain as described previously (Churn et al., 
1992a). Stained gels were dried and exposed to x-ray film (XRP-1, Kodak, Rochester, NY) 
for autoradiography. Autoradiographs were scanned using HP scanJet 4C/T high resolution 
scanner (Hewlett Packard, Boise, ID). Computer-assisted densitometry was utilized to 
quantitate intensities of the a; (50 kDa) and p (60 kDA) subunits ofCaM kinase II (Mocha0, 
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Jandel Corp., San Rafael, CA). 
Phosphocellulose Assay of CaM kinase II Phosphorylation of Syn tide II: 
Substrate phosphorylation was performed by the modification of a previously 
established procedure (Hashimoto and Soderling, 1987). For kinase activity, standard 
phosphorylation reactions were performed as described above, except that 60 µM Syntide 
II (Sigma Chemical Co., St. Louis, MO) was included in the mixture. This concentration of 
Syntide II has been demonstrated to provide maximal phosphate incorporation under 
standard conditions (Churn et al., 1995). The phosphorylation reactions were initiated by the 
addition of Ca2• , allowed to continue for I min and stopped by the addition of 20 µM 
EGTA. For Syntide II phosphorylation time course analysis and evaluation of phosphatase 
inhibition, standard reactions were carried out with ± 0.62 µM okadaic acid (phosphatase 
inhibitor) and reactions were run for 30s, 60s, 2, I 0, and 20 min before stopping with 20 µM 
EG TA. For both standard and time course phosphorylation analysis, 20 µl of the stopped 
reaction solution was immediately blotted onto phosphocellulose filter paper, P-81 
(Whatman, Maidstone England). Each reaction was measured in triplicate. Blotted P-81 
filters were then washed 3 times in 50 mM phosphoric acid to remove unincorporated 
phosphate, rinsed with acetone and allowed to air dry. Filters were placed in CytoScint™ 
scintillation fluid (Fischer Scientific, Fair Lawn, NJ) and incorporation of radioactive 
phosphate was measured using a Beckman LS 6500 scintillation counter (Beckman 
Instruments Inc., Fullerton, CA). 
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ex and P-CaM kinase II Immunoreactivity: 
Four to six micrograms of balanced proteins were blotted onto Trans-Blot® 
nitrocellulose membrane (Bio-Rad, Hercules,CA) Wlder vacuum filtration using a PR 600 
slot blot apparatus (Hoefer Scientific Instruments, San Francisco, CA). Antibody blot 
analysis was carried out using a Vectastain® ABC alkaline phosphatase staining kit (Vector 
Laboratories, Burlingame, CA). Briefly, protein blots were incubated overnight at 4 °c on 
a rotary shaker in a PBS-blocking solution containing: 5.0% dry milk (w/v), 0.05% TWEEN-
20 and 0.01 % anti-foam. Blots were then incubated in PBS-blocking solution containing a 
primary antibody specific for either cx-CaM kinase II (mouse monoclonal IgG, clone 6G9: 
BioMol, Plymouth Meeting, PA) or P-CaM kinase II (monoclonal IgG-3, clone 1C3-3D6 ) 
for 1 hour on rotary shaker at room temperature. Unbound antibody was removed by 3 
washes in PBS-blocking solution. Blots were then incubated with a biotinylated secondary 
antibody in PBS-blocking solution for 30 min at room temperature. Excess secondary 
antibody was removed by 3 washes with PBS. Labeled proteins were reacted with a 
peroxidase substrate solution and allowed to develop. The staining reaction was stopped by 
washing in several changes of dH20. Developed membranes were allowed to air dry, 
digitized using a HP ScanJet 4C!T high resolution scanner (Hewlett Packard, Boise, ID) and 
intensity measurements were obtained using a computer-assisted densitometer (Mocha0, 
Jandel Corp., San Rafael, CA). 
C. RESULTS: 
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Whole-cell patch-clamp analysis was carried out on low Mg++ and sham treated 
hippocampal cell cultures at selected time intervals following the treatment protocol. 
Electrophysiological analysis of control pyramidal neurons revealed normal activity 
exhibited by the presence of spontaneous excitatory postsynaptic potentials (EPSPs ), and the 
generation of occasional action potentials (Fig. IA). Following low Mg++ -treatment, 
hippocampal cultures displayed an enduring "epileptic" alteration evidenced by spontaneous 
recurrent seizure bursts that have previously been shown to range in duration from 20 sec to 
2 min with a resting membrane potential of neurons ranging between -50 to -65 m V (Sombati 
and DeLorenzo, 1995). Further expansion of one of the "epileptic" bursts reveals the 
presence of individual PDSs. Even further expansion reveals the complexity of the 
individual PDSs with a spike frequency discharge of approximately 17 Hz. The expression 
of this hyperexcitable state is a permanent alteration in these neuronal cultures in that the 
SRS activity has been shown to persists for the life of the culture (Sombati and DeLorenzo, 
1995). 
To determine the effect of low Mg++ exposure on hippocampal cell culture 
morphology, photomicrographs were obtained before and after treatment of cultures with 
Mg++-free media. Prior to treatment with Mg++ -free media, hippocampal neuron morphology 
was characterized by defined shaped somata with basal and apical dendritic fields extending 
outward; these characteristics fit the criteria for established models of hippocampal cell 
culture (Banker and Cowan, 1979). No obvious changes in cellular morphology were noted 
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in hippocampal cultures at different time points following treatment with low Mg++ -exposure 
when analyzed at the light microscopic level (Fig. 2). No changes in neuronal density were 
observed following the Mt• -free treatment. These findings demonstrated that no prominent 
changes in neuronal morphology or density occur as a result of low Mg++ -exposure and 
subsequent induction of SRSs. 
To determine if modifications in substrate phosphorylation by CaM kinase II activity 
were associated with the SRSs observed in this model, CaM kinase II-dependent 
phosphorylation of exogenously added synthetic peptide (Syntide II) was evaluated using 
established procedures (Churn et al., 1995) modified from (Hashimoto and Soderling, 1987). 
At different time intervals following the treatment regimen, homogenates were prepared from 
"epileptic" and control hippocampal neuronal cultures and proteins were processed and 
normalized for kinase assays. One day following induction of SRSs, a significant decrease 
in substrate phosphorylation of20.7±5.7% (p = 0.02, n = 5) was observed (Fig. l 0). At five 
days post induction of SRSs, a significant decrease of 18.9±8.4% ( p = 0.04, n = 5) was 
found in substrate phosphorylation from low-Mg++ treated hippocampal neuronal cultures 
(Fig. 11). Immediately following treatment (acute time point), CaM kinase II-dependent 
substrate phosphorylation was significantly decreased by 18.8±4.0% ( p = 0.006, n = 9) 
relative to sham controls (Fig. 12). These results demonstrate long-lasting reduction in CaM 
kinase II-dependent substrate phosphorylation in association with the induction of SRSs in 
hippocampal neuronal cultures. 
To further characterize CaM kinase II activity, endogenous phosphorylation analysis 
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was carried out under conditions for maximal CaM kinase II activity. Homogenates were 
prepared from control and low-Mg++ hippocampal cultures one day following treatment. 
Standard phosphorylation reactions were conducted, resolved on SDS-P AGE gel 
electrophoresis, and incorporation of [32P) into the a (50 kDa) and P (60 kDa) subunits of 
CaM kinase II was analyzed using standard procedures (Churn et al., 1995). Induction of 
SRSs in hippocampal neuronal cultures resulted in a dramatic reduction of phosphate 
incorporation into the a (50 kDa) and P (60 kDa) subunits of CaM kinase II (Fig. 13). 
Autoradiographic analysis and quantitation revealed a significant decrease in CaM kinase II­
dependent [ 32P) incorporation of26.7±5.0% (p =0.004, n = 5) and 19.0±5.7% (p =0.012, 
n = 5) into the a (50 kDa) and P (60 kDa) subunits ofCaM kinase II respectively (Fig. 14). 
This data demonstrates that a decrease in CaM kinase II-dependent endogenous 
phosphorylation is associated with the "epileptic" condition evidenced in low Mg++ treated 
hippocampal cultures. 
The induction of SRSs exhibited in this in vitro neuronal culture model of epilepsy 
has been shown to be an NMDA receptor, ca++-dependent mechanism (Sombati and 
DeLorenzo, 1995). To determine if the decrease in activity of CaM kinase II is dependent 
on induction of the SRS activity in this model, we carried out kinase assays on homogenate 
preparations obtained from low Mg++ treated hippocampal cultures with ± 25 µM D-APV 
(NMDA receptor antagonist). Neuronal Cultures were harvested immediately following the 
3 hour treatment regimen. Addition ofD-APV resulted in total blockade of the low Mg++­
induced reduction in CaM kinase II-dependent substrate phosphorylation when compared to 
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controls and low Mg++ alone preparations (Fig. 12). This finding demonstrates a direct 
correlation between the induction of the "epileptic" condition and decrease in activity of 
CaM kinase II observed in the hippocampal neuronal culture model of epilepsy. 
The decrease in [32P] incorporation into the exogenous Syntide II substrate or the a 
(50 kDa) and p (60 kDa) subunits of CaM kinase II could be attributed to other ca++­
dependent mechanisms occurring in this model. Induction of selected phosphatases would 
reflect a decrease in phosphate incorporation as observed above. To address this question, 
we carried out a Syntide II phosphorylation reaction time course± 0.62 µM okadaic acid 
(phosphatase inhibitor) using low Mg++ and control hippocampal culture homogenates 
isolated 24 hours post-treatment. Addition of okadaic acid to the phosphorylation reactions 
did not block the reduction in CaM kinase II-dependent substrate phosphorylation observed 
in low Mg++ treated hippocampal cultures (Fig. 15). Since standard kinase-dependent 
substrate phosphorylation reactions are 60 sec in duration, quadruplicate reactions were run 
at this time point, and values were plotted as a percent of control (Fig. 16). This data 
indicates that induced phosphatase activity is not a contributing factor to the reduction in 
phosphate incorporation observed in "epileptic" hippocampal cultures. 
Several different modifications of the CaM kinase II enzyme pathway could account 
for the decrease in activity observed with low Mg++ treated hippocampal neuronal cultures. 
To assess if alterations in protein levels for the a and p subunits of CaM kinase II were 
associated with the observed decrease in enzyme activity, immunoreactivity for both a and 
P-CaM kinase II was measured at specified times post Mg++ -free exposure using protein slot 
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blot analysis with specific antibodies previously characterized by Western blot techniques 
used in our laboratory (Chum et al., 1995). Immediately following the 3 hour low Mg++ 
treatment regimen, a significant decrease of 7 .04±2.3% ( p = 0.03, n = 5) in a. subunit 
protein levels were observed compared to control (Fig. 17). No significant changes were 
seen in p subunit imrnunoreactivity at this time point (Fig. 18). One day following Mg++-free 
treatment resulted in a significant decrease of 13.1±1.7% (p = 0.004, n = 5) and 12.7±0.9% 
(p = 0.008, n = 5) in a. and P-CaM kinase II imrnunoreactivity respectively (Fig. 19 and 20). 
These results suggest that modest but significant reductions in CaM kinase II 
imrnunoreactivity are associated with induction of SRSs in hippocampal neuronal cultures. 
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Figure 10. Seizure-induced inhibition of kinase-dependent substrate phosphorylation 
of Syntide II in neuronal culture homogenates isolated 24 hours post-low Mg++ treatment. 
Data are expressed as the mean± SEM of control (n = 5). * ,p � 0.02, Student's t-test. 
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Figure 11. Seizure-induced inhibition of kinase-dependent substrate phosphorylation 
of Syntide II in neuronal culture cytosolic fraction isolated 5 days post-low Mg++ 
treatment. Data are expressed as the mean± SEM of control (n = 5). *, p � 0.04, 
Student's t-test. 
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Figure 12. Effect of NMDA receptor blockade during low Mg++ treatment on 
seizure-induced inhibition of kinase-dependent substrate phosphorylation ofSyntide II in 
neuronal culture homogenates isolated immediately following the treatment protocol. 
Hippocampal cultures were low Mg++ treated with ±25 µM D-APV (NMDA receptor 
antagonist). Data are expressed as the mean± SEM (control: n = 9, low Mg++ : n = 9, low 
Mg++ + APV: n = 5). *,p = 0.009, one-way ANOVA. 
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Figure 13. Effect of seizure-induction on endogenous CaM kinase II activity in 
hippocampal neurons 24 hours post-low Mg++ treatment. Protein stain and 
autoradiograph from a representative SOS-PAGE gel of control and "epileptic" 
hippocampal neuronal culture homogenates reacted under standard conditions for CaM 
kinase II activity (see methods). Phosphorylation reactions were carried out in the 
presence ( +) or absence (-) of Ca++ and calmodulin. Lanes I and 2 represent controls 
reaction. Lanes 3 and 4 represent low Mg++ treatement. Arrows denote the a (50 kDa) 
and p (60 kDa) subunits ofCaM kinase II. 
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Figure 14. Quantification of endogenous CaM kinase II activity from "epileptic" 
hippocampal neuronal culture homogenates 24 hours post-low Mg++ treatment. 
Phosphorylation of both a (50 kDa) and 13 (60 kDa) subunits ofCaM kianse II was 
measured (see Methods). Data are expressed as the mean± SEM (n = 5, each). * ,p::; 
0.006, Student's t-test. 
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Figure 15. Reaction duration time course for kinase-dependent substrate 
phosphorylation ofSyntide II in homogenates from control ( -0-) and low Mg++ ( -•- ) 
hippocampal cultures 24 hours post-treatment. Reaction durations were 30 s, 60 s, 2, I 0 
and 20 min to determine Syntide II phosphorylation saturation curves. 
A. Phosphorylation reactions carried out in the presence (+)or, B. absence(-) of okadaic 
acid (phosphatase inhibtor). Data are expressed as counts per minute (CPM) ± SEM of 
duplicate quantitations (quadruplicate quantitations were carried out for the 60 s time 
point). 
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Figure 16. Kinase-dependent substrate phosphorylation of Syntide II in neuronal 
culture homogenates isolated 1 day post-low Mg++ -treatment. Standard one minute 
reactions were carried out with± okadaic acid (OA). Quadruplicate reactions were run 
on pooled samples from sham and low Mg++ treated groups. Data are expressed as the 
mean±SEM. 
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Figure 17. Protein blot analysis of homogenates from control and low Mg++ 
hippocampal neuronal cultures immediately following treatment. A. Antibody staining of 
control and low Mg++ hippocampal neuronal culture protein blots using a rnAB specific 
for ct-CaM kinase II (see methods). B. Quantification of ct-CaM kinase II antibody 
staining in control and low Mg++ cultures immediately following treatment. Data are 
expressed as the mean± SEM (n = 5, each). * p s; 0.03, Student's t-test. 
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Figure 18. Protein blot analysis of homogenates from control and low Mg++ 
hippocampal neuronal cultures immediately following treatment. A. Antibody staining of 
control and low Mg++ hippocampal neuronal culture protein blots using a mAB specific 
for P-CaM kinase II (see methods). B. Quantification of P-CaM kinase II antibody 
staining in control and low Mg++ cultures immediately following treatment. Data are 
expressed as the mean± SEM (n = 5, each). 
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Figure 19. Protein blot analysis of homogenates from control and low Mg++ 
hippocarnpal neuronal cultures 24 hours post treatment. A. Antibody staining of control 
and low Mg++ hippocarnpal neuronal culture protein blots using a rnAB specific for a­
CaM kinase II (see methods). B. Quantification of a-CaM kinase II antibody staining in 
control and low Mg++ cultures 24 hours post treatment. Data are expressed as the mean± 
SEM (n = 5, each). * p :S: 0.004, Student's t-test. 
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Figure 20. Protein blot analysis of homogenates from control and low Mg++ 
hippocampal neuronal cultures 24 hours post treatment. A. Antibody staining of control 
and low Mg++ hippocampal neuronal culture protein blots using a mAB specific for P­
CaM kinase II (see methods). B. Quantification of P-CaM kinase II antibody staining in 
control and low Mg++ cultures 24 hours post treatment. Data are expressed as the mean± 
SEM (n = 5, each). * p � 0.0008, Student's t-test. 
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D. DISCUSSION: 
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Our results demonstrate a long-lived decrease in CaM kinase II activity in association 
with the enduring expression of SRSs in a hippocampal neuronal culture model of epilepsy. 
Exposure of hippocampal cultures to a Mg++ -free media for 3 hours results in the induction 
of an "epileptic" condition evidenced by the long-lasting presence of seizure activity (Fig. 
1). No obvious changes in neuronal culture morphology or density were observed in 
association with the seizure activity exhibited in this model (Fig. 2). This change in CaM 
kinase II function occurs immediately and continues as far out as 5 days following induction 
of the "epileptic" condition (Fig. 10-12). Furthermore our findings demonstrate a significant 
decrease in endogenous phosphorylation of the ex (50 kDa) and P (60 kDa) subunits of CaM 
kinase II in association with the SRS activity in these hippocampal cultures (Fig. 13 and 14). 
The epileptiform activity observed in low Mg++ treated hippocampal cultures has been 
shown to be associated with rapid increases in intracellular ca++ levels (Sombati and 
DeLorenzo, 1995). The entry of Ca++ into neuronal cells acts as a major second messenger 
pathway involved in regulating a multitude of cellular processes. Induction of calcium­
dependent phosphatases is one such process. Epileptiform-induced activation of these 
enzymes could contribute to the reduction of phosphate incorporation observed in substrate 
and endogenous phosphorylation analysis from low Mg++ treated hippocampal culture 
preparations. We demonstrated that inhibition of phosphatase activity by okadaic acid did 
not block the decrease in CaM kinase II activity associated with the "epileptic" condition in 
these hippocarnpal neuronal cultures (Fig. 15 and 16). This finding further substantiates that 
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the reduction in phosphate incorporation seen with low Mg++ treatment is due to a decrease 
in activity of CaM kinase II. 
Much work in the field of epilepsy research has centered on the investigation of what 
transduction pathways are involved in epileptogenesis. A number of studies have implicated 
a role for NMDA receptor activation in the development of seizure discharges. Blockade of 
NMDA receptor function has been shown to impede the induction of several models of 
seizures and epilepsy which include kindling (Sutula et al., 1996) electrically induced status 
epilepticus (Young and Dragunow, 1994; Stringer and Lothman, 1992), and low Mg++­
induced seizure-like discharges in a hippocampal slice preparation (Anderson et al., 1987). 
Induction of SRS activity by low Mg++ treatment of hippocampal neuronal cultures has 
previously been shown to be an NMDA receptor, ea++_dependent mechanism (Sombati and 
DeLorenzo, 1995). We have demonstrated that the enduring reduction in CaM kinase II 
activity observed in this in vitro hippocampal culture model of epilepsy is dependent on 
NMDA receptor activation (Fig. 12). This finding gives evidence for a direct correlation 
between induction of the "epileptic" condition and decline in activity of CaM kinase II 
observed in low Mf• treated hippocampal cultures. 
The mechanism(s) involved in the suppression ofCaM kinase II activity in 
association with this model of epilepsy may be attributed to modification of the enzyme 
system at several different cellular levels of regulation. Decrease in expression of CaM 
kinase II mRNA has been shown to occur in a models of seizures and epilepsy (Bronstein et 
al., 1992; Murray et al., 1995). Post-translational modification in CaM kinase II activity has 
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also been demonstrated in several models of neurotrauma which include stroke (Churn et al., 
1992a; Churn et al., 1993a), status epilepticus (Bronstein et al., 1988; Perlin et al., 1992; 
Wasterlain et al., 1992), and epilepsy (Goldenring et al., 1986; Wasterlain and Farber, 1984). 
These observations suggest a decrease in efficacy of CaM kinase II which is not attributable 
to proteolytic degradation, but rather the result of a selective modification of the enzyme at 
the functional level. 
Our data demonstrates a modest but significant decrease in protein levels for both the 
a and � subunits of CaM kinase II in association with induction of SRSs in hippocampal 
neuronal cultures (Fig. 17-20). No obvious changes in neuronal culture morphology or 
density are observed in this model of epilepsy. In contrast to these findings, glutamate­
induced excitotoxicity in cultured cortical neurons resulted in a dramatic loss of CaM kinase 
II immunoreactivity which preceded the delayed cell death associated with this model (Churn 
et al., 1995). In consideration of these observations, one could postulate that the degree of 
loss in CaM kinase II protein expression may be directly related to extent of the 
neuropathological repercussions, ranging from maladaptive changes in neurophysiology ( i.e. 
epilepsy) to excitotoxicity-induced neuronal cell death. Further studies are merited for a 
more thorough investigation of altered CaM kinase II protein expression at the cellular level 
and how it may play a role in the decrement of enzyme activity observed in this in vitro 
model of epilepsy. 
The "epileptic" condition displayed in low Mg++ treated hippocampal cultures shares 
pathophysiological characteristics observed in intact models of seizures and epilepsy, and 
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responds to anticonvulsant drugs commonly used to treat human epilepsy disorders (Sombati 
and DeLorenzo, 1995). Thus, this in vitro model of enhanced neuronal excitability lends 
itself as an effective tool towards the elucidation of the molecular mechanisms involved in 
the propagation and maintenance of seizures and epilepsy. Our results demonstrate a 
significant and long-lasting decrease in activity of the multifunctional CaM kinase II enzyme 
in association with the induction and maintenance of SRSs in hippocampal cultures and may 
contribute to the underlying mechanisms responsible for the pathophysiology observed in this 
in vitro model of epilepsy. Future studies are warranted to investigate the specific 
contribution of altered CaM kinase II activity towards the generation of epileptiform 
discharges evident in these hippocampal neuronal cultures. 
Ca++/CALMODULIN-DEPENDENT PROTEIN KINASE II REGULATION OF 
GABA
A 
RECEPTOR FUNCTION IN HIPPOCAMPAL NEURONAL CULTURES: 
A. INTRODUCTION: 
The y-amino butyric acid type A (GABA,J receptor is the primary mediator of fast 
inhibitory synaptic transmission in the central nervous system. Upon binding of its 
endogenous ligand GABA, the receptor channel gates the influx of the chloride anion 
inducing a hyperpolarized state culminating in inhibition of excitatory synaptic transmission. 
The GABAA receptor channel is a member of the ligand-gated ion channel superfamily which 
maintain several criteria for receptor subunit structure. These include the presence of four 
highly conserved transmembrane spanning regions, a large NH2-terminal extracellular 
domain containing N-linked glycosylation sites and cysteine loops important in binding of 
GABA and other ligands to the receptor channel, a large intracellular loop between 
transmembrane regions 3 and 4, and pentameric in structure (Barnard et al., 1987). To date, 
13 different GABAA receptor subunits have been isolated and cloned which include a:1_., p,_3, 
y 1•3, and one 6. The regional differences in expression patterns for the GABAA receptor 
subunits underscore the functional heterogeneity observed with this receptor channel 
throughout the CNS (McKeman and Whiting, 1996). 
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All of the GABAA receptor subunits contain at least one consensus site for kinase­
dependent protein phosphorylation within the intracellular loop. This is believed to be one 
of the underlying mechanisms involved in the functional heterogeneity observed with this 
receptor complex throughout the CNS (Bureau and Laschet, 1995; Sigel, 1995). 
Phosphorylation-dependent regulation of GABA A receptor function by different transduction 
pathways has been demonstrated in a number of studies. Transduction systems involved 
have been shown to include NMDA receptor activation (Chen and Wong, 1994; Stelzer and 
Shi, 1994), nitric oxide production (Robello et al., 1996), protein kinase G (Leidenheimer, 
1996), protein kinase A (Feigenspan and Bormann, 1994), protein kinase C (Krishek et al., 
1994; Sigel et al., 1991) and ca++/calmodulin-dependent protein kinase II (Kano et al., 1996; 
McDonald and Moss, 1994; Wang et al., 1995). A role for protein phosphatases in the 
regulation of GABA A receptor response has also been demonstrated (Martina et al., 1996). 
Regulation of the GABAA receptor by phosphorylation-dependent mechanisms can result in 
either enhancement or suppression of channel function depending upon which transduction 
pathway is mediating the effect and in what brain region it is occurring. 
The Ca++ ion acts as a major second messenger in the central nervous system. 
Changes in intracellular Ca++ concentration have been shown to be involved in regulating a 
wide range of cellular events including neurotransmitter release, dendritic sprouting, 
transcriptional control and learning and memory (Ghosh and Greenberg, 1995). Calcium 
produces its action by the biochemical modulation of a multitude of intracellular proteins 
some of which include kinases, phosphatases, proteases and transcription factors. One such 
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protein is Ca++/calmodulin-dependent kinase II (CaM kinase II), a multifunctional enzyme 
system that is highly enriched in the CNS. Activation of CaM kinase II has been implicated 
in mediating a number of cellular processes some of which include neurotransmitter 
biosynthesis and release, cytoskeletal structure, regulation of receptor-gated and voltage­
dependent ion channels, and transcriptional control (Bronstein et al., 1993). 
Recent findings have demonstrated that CaM kinase II acts to positively modulate 
GABAA receptor response. Wang et al. (1995) found that intracellular application of an 
active, Ca++-independent (autothiophosphorylated) form of a CaM kinase II resulted in 
enhancement of GABAA receptor response in both rat spinal dorsal horn and CA I 
hippocampal neurons. This augmentation of GABAA response was reflected by an increase 
in both current amplitude and muscimol sensitivity of the receptor channel. In addition, they 
demonstrated that application of calyculin A (phosphatase inhibitor) also resulted in 
increased GABAA receptor function in these neuronal preparations, suggesting a 
phosphorylation-dependent mechanism. A long-lasting ca++ -dependent potentiation of 
GABA-mediated inhibitory synaptic currents has been demonstrated in cerebellar Purkinje 
neurons (Kano, 1994). Inhibition of CaM kinase II with either selective kinase inhibitors 
(staurosporin or calmodulin-binding domain) or specific CaM kinase II inhibitors 
(calmidazolium or KN62) resulted in blockade of the Ca++_dependent "rebound potentiation" 
of GABA-mediated inhibition observed in cerebellar slices (Kano et al., 1996). Churn and 
DeLorenzo (1996) have shown that addition of purified rat brain CaM kinase II to a synaptic 
plasma membrane preparation significantly increased [3H]-muscimol binding and that 
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inhibition of CaM kinase II by selective agents blocked this effect. In light of these findings, 
it can be inferred that CaM kinase II acts to positively modulate GABAA receptor response 
in these neuronal preparations. 
In the present study, we set out to investigate the role ofCaM kinase II in regulating 
GABAA receptor function in primary hippocampal neuronal cultures. We used several 
experimental approaches to suppress the activity of the CaM kinase II enzyme system in 
these cell cultures and then studied GABAA receptor function using whole-cell patch-clamp 
analysis. The results indicate that inhibition CaM kinase II results in decreased GABAA 
receptor function in hippocampal neuronal cultures. 
B. METHODS: 
Primary Hippocampal Neuronal Cultures: 
Primary hippocampal cultures were prepared by a modification of the method of 
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from 
2-day postnatal Sprague-Dawley rat pups were dissected out from the brain and prepared for 
tissue culture by 0.25% trypsin digestion followed by trituration through a Pasteur pipet. 
Triturated cells were then counted by cresyl violet blue exclusion analysis using a 
hemocytometer, and 2 x 105 cells were plated on a 35 mm dish previously coated with 
growth factor reduced MATRIGEL® matrix (Collaborative Biochemical, Bedford, MA) to 
aid in the attachment of the hippocampal cells. One day following plating, cultures were 
treated with 5 µM cytosine arabinoside to inhibit further non-neuronal cellular proliferation. 
Hippocampal cultures were maintained in MEM containing N3 supplement media plus 20% 
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conditioned media. The N3 supplement contained 25 mM HEPES buffer (pH 7.4), 2 mM 
glutamine, 5 µg!ml Insulin, 100 µg!ml transferrin, 100 µM putrescine, 30 f]M sodium 
selenite, 20 f]M progesterone, 1 mM sodium pyruvate, 0.1 % ovalbumin, 20 f]g/ml T3, 40 
t']g/ml corticosterone. Conditioned media was obtained from confluent hippocampal glia 
beds plated out at a density of 1.0 x 106 cells/75 cm2 flasks and maintained in MEM 
containing 10% fetal bovine serum and 2 mM glutamine. Both hippocampal cell cultures 
and glia beds were maintained at 37°C under 5% CO2 95% air. 
a CaM kinase II Antisense Knockdown Analysis: 
Antisense and missense oligonucleotide probes were constructed (Operon 
Technologies Inc., Alameda, CA). For the a CaM kinase II knockdown, an antisense 
oligonucleotide complementary to the +1 to +18 nucleotides was constructed with the 
following sequence: 5' GGT AGC CAT CCT GGC ACT 3'; missense sequence for a CaM 
kinase II was: 5' GGT AGC CAT AAG GGC ACT 3'. Knockdown analysis for a CaM 
kinase II involved treating hippocampal cultures for 5 days with 3.0 µM of either antisense 
or rnissense oligonucleotides every 24 hours. During the treatment regimen, hippocampal 
cultures were maintained in N3 supplement containing 20% conditioned media at 37°C under 
5% CO2 95% air. At the end of the 5 day treatment protocol, cultures were utilized for 
electrophysiological analysis. 
Inhibition of CaM Kinase II with KN93: 
Hippocampal cultures were treated with either 1 µM KN93 (specific CaM kinase II 
inhibitor) or 1 µM KN92 (structurally similar inactive control) for three days during which 
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time they were maintained in N3 supplement containing 20% conditioned media at 37 °C 
under 5% CO2 95% air. At the end of the 3 day treatment protocol, cultures were utilized for 
electrophysiological analysis. 
Electro physiological Analysis of IPSC Amplitudes: 
For electrophysiological analysis of spontaneous IPSC amplitude, voltage-clamp 
recordings were performed using procedures similar to what was utilized by Soltesz et al. 
(1995). Briefly, culture medium was changed to recording solution containing (in mM) 1 
TDC, 25 APV and 10 CNQX, 145 NaCl, 2.5 KC!, 10 HEPES, 1 MgCl2, 2 CaCl2, 10 glucose, 
.002 glycine, pH 7.3 and osmolarity adjusted to 325 mOsm with sucrose. Cultures were then 
mounted on the stage of an inverted microscope (Nikon Diaphot, Japan) and continuously 
perfused with recording solution. Patch electrodes with a resistance of2-4 MQ were pulled 
on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, CA) and then fire 
polished. The pipet solution contained (in mM) 140 CsCl, 1 MgC12, 10 HEPES, 1.1 EGTA 
and adjusted to pH 7 .2 with CsOH and 310 mOsm with sucrose. After the patch-clamp was 
established on a pyramidal neuron, the membrane potential was clamped at -50 mV and 
voltage-clamp recording mode was employed using an Axopatch lD amplifier (Axon 
Instruments, Foster City, CA). Data was digitized and transferred to video tape using a PCM 
device (Instrutech, Mineola, NY; 18 kHz sampling frequency) and then played back on a DC-
500 Hz chart recorder (Astro-Med Dash II, Warwick, RI). To evaluate the IPSCs, 
digitization analysis and detection of individual rnIPSCs were done using the Strathclyde 
Electrophysiology Software WCP Vl.2 (Dagan Corporation, Minneapolis, MN) and IPSC 
amplitudes and frequencies were determined. 
C. RESULTS: 
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Antisense oligonucleotide DNA probes were used to suppress (knockdown) ex CaM 
kinase II in primary hippocampal cultures. ex CaM kinase II antisense treatment of 
hippocampal cultures has previously been shown to significantly decrease protein expression 
of this enzyme (Sombati et al., 1996). Hippocampal neuronal cultures were treated for 5 
days with either ex CaM kinase II antisense or missense ( control) probes (3 µM). Intracellular 
recordings from pyramidal neurons using whole-cell voltage-clamp mode displayed dramatic 
reductions in the amplitude ofIPSCs in neuronal cultures treated with antisense probe (Fig. 
21). Quantification of IPSC amplitude by digitization analysis revealed a significant 
reduction of 37.5±4.3% (p = 0.002, n = 4) in the antisense-treated group as compared to 
missense controls (Fig. 22). Previous work has demonstrated that antisense "knock-down" 
of ex CaM kinase II in these hippocampal cultures results in a state of profound neuronal 
hyperexcitability (Sombati et al., 1995). Thus, these findings strongly suggest a role for the 
regulation of GABAA receptor function by CaM kinase II in hippocampal neuronal cultures. 
The suppression of its activity results in a loss of GABAergic function and an increase in 
neuronal excitability. 
To further investigate the association between regulation GABAA receptor function 
and the CaM kinase II transduction pathway, hippocampal cultures were treated with either 
1.0 µM KN93 (specific inhibitor ofCaM kinase II) or l.O µM KN92 (chemically similar 
inactive agent) for three days, and GABAA receptor function was analyzed. 
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Electrophysiological analysis using whole-cell voltage-clamp mode revealed that KN93 
treatment resulted in a significant decrease of21.5±3.3% (p ,5; 0.0001, KN93: n = 16, KN92: 
n = 11) in IPSC amplitude as compared to KN92 treated control cultures (Fig. 23). These 
results further substantiate the involvement of CaM kinase II in mediating GABAA receptor 
response in these hippocampal culture preparations. 
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Figure 21. Voltage-clamp analysis ofhippocampal cultures treated with missense 
(control) and antisense oligonucleotide probes constructed against a CaM kinase II. 
Representative voltage-clamp recordings of spontaneous inhibitory postsynaptic currents 
(IPSCs) from hippocampal cultures following 5 days of treatment with A. missense or 
B. antisense oligonucleotide probes. 
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Figure 22. Quantification of spontaneous inhibitory postsynaptic current (IPSCs) 
amplitudes from hippocampal neuronal cultures after 5 days of treatment with antisense 
or missense (3 µM) oligonucleotide probes complementary to a CaM kinase II . Data are 
expressed as the mean± SEM of control (missense) (missense: n = 4, antisense: n = 4). 
*,p = 0.001, Student's t-test. 
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Figure 23. Quantification of spontaneous inhibitory postsynaptic current (IPSCs) 
amplitudes from hippocampal neuronal cultures after 3 days of treatment with the 
specific CaM kinase II inhibitor KN93 (1 µM). Data are expressed as the mean± SEM 
of control (control: n = 11, KN93: n = 16). *,p = 0.0001, Student's t-test. 
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D. DISCUSSION: 
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This investigation demonstrates that experimental suppression of CaM kinase ll 
activity results in a significant decrease of GABAA receptor function in primary hippocampal 
neuronal cultures. Antisense oligonucleotide knockdown of a CaM kinase ll subunit 
expression in hippocampal neuronal cultures results in a significant reduction of spontaneous 
inhibitory postsynaptic current (IPSC) amplitude. Furthermore, treatment of hippocampal 
neuronal cultures with the specific CaM kinase II inhibitor KN93 also results in a significant 
attenuation oflPSC amplitude. This data provides direct evidence that the CaM kinase II 
transduction pathway acts to regulate GABAA receptor function at the postsynaptic 
membrane in hippocampal neuronal cultures. 
The mechanism(s) by which inhibition of the CaM kinase II transduction 
pathway acts to attenuate GABAergic inhibitory function in hippocampal neuronal cultures 
is unclear. CaM kinase II is a multifunctional enzyme system that has been implicated in 
mediating many cellular processes through transcriptional, translational and post­
translational regulatory mechanisms (Churn, 1995). Phosphorylation of selective 
transcription factors such as the serum response factor (SRF), ca••-response element (CaRE) 
and the cAMP response element binding protein (CREB) by CaM kinase II has been 
demonstrated and implicates a role for CaM kinase II in transcriptional control (Ghosh and 
Greenberg, 1995; Miranti et al., 1995). One could postulate that alterations in the CaM 
kinase II transduction pathway evokes the expression of a maladaptive phenotype. Aberrant 
changes in neuronal plasticity could result in pathophysiological consequences contributing 
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to a state of abnormal synaptic transmission. To date, little is known about what specific role 
CaM kinase 11 has in controlling long-term expression of neuronal genes. More 
investigations are merited to determine the involvement of CaM kinase II at this level of 
cellular regulation. 
Post-translational modification of GABAA receptor function by phosphorylation­
dependent mechanisms has been well established (Bureau and Laschet, 1995). Kinase­
dependent phosphorylation can act to either suppress or enhance GABAA receptor response 
contingent upon which transduction pathway is involved (Chen and Wong, 1994; Feigenspan 
and Bormann, 1994; McDonald and Moss, 1994; Sigel, 1995; Valenzuela et al., 1995; Wang 
et al., 1995). The Pl , P2 and y2 GABAA receptor subunits have been shown to contain 
consensus sites for CaM kinase II-dependent phosphorylation (McDonald and Moss, 1994). 
In a synaptic plasma membrane preparation, addition of purified CaM kinase II acts to 
significantly enhance [3H]-muscimol binding (Churn and DeLorenzo, 1996). Rebound 
potentiation of GABA-mediated currents in a Purkinje neuronal preparation has been shown 
to be both a phosphorylation and CaM Kinase II-dependent phenomenon (Kano et al., 1996). 
Intracellular injection of an active form of a CaM kinase II into either acutely isolated rat 
spinal dorsal horn neurons or CA 1 hippocampal neurons has been shown to result in a 
significant enhancement of GABAA receptor function. In addition, inhibition of phosphatase 
1 and 2A with calyculin A also resulted in a dramatic increase in GABAA receptor response 
in these neuronal preparations (Wang et al., 1995). 
The data presented in this study demonstrates that suppression of CaM kinase II 
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results in decreased GABAA receptor function in hippocampal neuronal cultures. Given the 
3 to 5 day treatment window utilized in this study to suppress CaM kinase II activity, the 
exhibited alterations in GABAA channel function could be attributed to aberrant changes in 
cellular regulation at multiple levels. Further investigations are warranted to elucidate the 
specific mechanism(s) responsible for CaM kinase II-dependent modulation of GABAergic 
inhibitory processes in hippocampal neuronal cultures. 
GENERAL DISCUSSION: 
The results of this research effort test the central hypothesis and demonstrat that 
alterations in GABAA receptor expression and enduring suppression in activity of the 
multifunctional ca++/calmodulin-dependent protein kinase II system are associated with the 
induction of SRS activity in a hippocampal neuronal culture model of epilepsy. In addition, 
we show that experimental suppression of CaM kinase II results in a decrease in GABAA 
receptor function in hippocampal neuronal cultures. Epilepsy is a complicated condition that 
comprises many etiologies and possible causes. A better understanding of the underlying 
mechanisms of epileptogenesis will allow for a more effective development of therapeutic 
interventions for the treatment of this condition. 
Suppressed GABAergic inhibitory function is thought to be one of the primary 
mechanisms which contribute to epileptogenesis. Altered GABAA-dependent inhibitory 
processes have been demonstrated in a number of models of seizures and epilepsy (Evans 
et al., 1994; Isokawa, 1996; Kamphuis et al., 1992; Kapur and Lothman, 1989; Kapur et al., 
1989; Luhmann et al., 1995; Mangan et al., 1995; Merlin and Wong, 1993). Alterations in 
several of the modulatory sites on the GABAA receptor channel have been shown to occur 
in models of seizures and epilepsy. These include a decrease in BZ sensitivity (Churn et al., 
1997; Kapur and Macdonald, 1997), a decrease in [3HJ-muscimol binding (Kapur et al., 
125 
126 
1994; Rice et al., 1996) and a change in Zn++ sensitivity (Buhl et al., 1996; Kapur and 
Macdonald, 1997). The underlying mechanism(s) that accounts for the change in GABAA 
receptor function is unclear, but may involve alterations in the expression of selected receptor 
subunits resulting in an abnormal assembly of the receptor channel. 
Our data demonstrate that induction of SRS activity in hippocampal neuronal cultures 
results in a decrease in expression of GABAA ex2 and ex5 mRNA levels. A concurrent 
decrease in BZ binding in hippocampal membrane preparations from low Mg++ treated 
cultures indicates a decrease in GABAA ex subunit protein expression associated with the 
induction of the "epileptic" condition in this model. Of the GABAA ex subunit class, the ex2 
and ex5 are the most abundantly expressed in the hippocampus (Wisden et al., 1992). A 
reduction in their expression could impart a substantial decrement in the ex subunit protein 
contribution to the GABAA receptor assembly, resulting in an altered function of the channel 
complex. Utilizing this in vitro model of epilepsy, Gibbs et al. (1997b) have demonstrated 
that induction of SRS activity in hippocampal cultures was associated with a significant 
decrease in both the potency of GABA and sensitivity of clonazepam augmentation for the 
GABAA receptor channel. Our findings of a long-lasting decrease in GABAA ex subunit 
expression in this in vitro model of epilepsy occurs in conjunction with a significant decrease 
in GABAA receptor function. Other studies have found similar results with GABAA receptor 
expression in models of seizures and epilepsy. A chronic model ofpilocarpine-induced TLE 
in the rat has been shown to demonstrate significant and long-lived decreases in mRNA 
levels for GABAA ex2 and ex5 receptor subunits (Houser et al., 1995; Rice et al., 1996). In 
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addition, low Mg++ -evoked SRSs in hippocampal entorhinal cortical slices have been shown 
to result in a significant decrease in GABAA a2 mRNA expression (Vick et al., 1996). In 
light of these findings and the results we have presented thus far, one could postulate that 
alterations in GABA A receptor expression may contribute to the decrease in channel function 
observed in models of seizures and epilepsy. 
Whether the decrease in GABAA a subunit expression is a contributing factor to the 
reduction in GABAA receptor function and subsequent generation of epileptiform activity 
observed in this model is unclear. Using GABAA a2 antisense oligonucleotide (knock-down) 
technology, we demonstrate that suppression of this receptor protein subunit evokes a 
reduction in GABAA-dependent inhibitory function. Thus, the selective decrease in GABAA 
a subunit expression exhibited in "epileptic" neuronal cultures is capable of incurring a 
decrement in GABAA receptor response. 
The allosteric properties that each GABAA receptor subunit confers on receptor 
channel function have been determined by the use of recombinant receptor studies and 
expression systems (Benke et al., 1991; Herb et al., 1992; Levitan et al., 1988; Malherbe et 
al., 1990; McKeman and Whiting, 1996; Ymer et al., 1989; Ymer et al., 1990). Earlier work 
determined that the presence of one or more of the y subunits were necessary for 
benzodiazepine sensitivity of the receptor complex, establishing a minimum assembly 
requirement of a.P. Yx for the majority of GABAA receptors throughout the brain (Benke et 
al., 1991 ). The contributions of the a subunits have been shown to be essential to the 
GABAA receptor complex. They contain the binding site for the BZs and contribute to the 
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affinity of GABA binding to the receptor complex (Burt and Kamatchi, 1991). Co-
expression of the a5 with �2 and y2 subunits has been demonstrated to produce a receptor 
complex with the highest affinity for GABA when compared to other subunit combinations 
studied. The a5 subunit confers positive cooperativity of GABA channel gating, a functional 
property exhibited by native GABAA receptors (Sigel et al., 1990). Recent findings by 
Fritschy and colleagues ( 1997) suggest that the contribution of a GABA A receptor a subunit 
is essential for proper receptor formation in vivo. Using a mutant mouse model that lacks 
expression of the GABA A a5 receptor subunit due to a homozygous deletion of chromosome 
7, they demonstrated that the absence of this subunit prevented the assembly of a subclass 
of GABAA receptors in the hippocampal formation, with a subsequent decrease in BZ 
binding. In addition, there was a reduction in immunoreactivity for the �2 and y2 subunits 
in the hippocampus of these mutant mice. In light of these studies, the decrease in GABAA 
a subunit expression we observed in association with SRS activity in hippocampal neuronal 
cultures could result in an aberrant channel formation. Such an alteration might cause the 
suppression of GABA A receptor function and the subsequent generation of the epileptiform 
discharges observed with this model. 
Increase in intracellular Ca++ concentration plays an integral role in the transduction 
of extracellular signals to multiple regulatory mechanisms within the cell by its action on 
many different effector proteins (Baimbridge et al., 1992). Depending on the extent of Ca++ 
entry into neurons, alterations can occur ranging from potentiation of synaptic transmission 
to excitotoxic cell death. Thus, the intricate regulation of Ca++ homeostasis is fundamental 
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to neuronal cell function and viability. The induction of SRS activity in hippocampal 
neuronal cultures has been shown to be a Ca++-dependent mechanism (Sombati and 
DeLorenzo, 1995). In addition, the chronic epileptiform discharges evidenced in low Mg++ 
treated hippocampal cultures have been shown to be associated with rapid rises in 
intracellular ca++ concentrations. These observations imply that a ca++-dependent 
mechanism(s) is responsible for the induction and possibly maintenance of the "epileptic" 
condition displayed in low Mg++ treated hippocampal neuronal cultures. 
CaM kinase II is a multifunctional enzyme that is highly enriched in the brain and 
mediates many cellular processes essential to neuronal function and viability (Bronstein et 
al., 1993). Phosphorylation-dependent regulation of substrates by CaM kinase II enables its 
control over many cellular functions. These include neurotransmitter biosynthesis and 
release, transcription, cytoskeletal structure and regulation of ligand-gated and calcium­
dependent ion channels (Churn, 1995). Alterations in the activity of CaM kinase II have 
been demonstrated in association with models of neurotrauma. These include NMDA 
receptor-dependent excitotoxicity (Churn et al., 1995), stroke (Churn et al., 1992a; Hanson 
et al., 1994), pilocarpine-induced TLE (Kochan et al., 1997), kindling (Goldenring et al., 
1986; Wasterlain and Farber, 1984) and status epilepticus (Bronstein et al., 1988; Churn et 
al., 1991; Perlin et al., 1992; Wasterlain et al., 1992). In addition, decreases in both CaM 
kinase II imrnunoreactivity (Bronstein et al., 1990) and mRNA expression (Bronstein et al., 
1992) have been demonstrated in the kindling model of epilepsy. A transgenic mouse model 
carrying a null mutation (-/-) for the a subunit of CaM kinase II has been shown to exhibit 
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severe neuronal hyperexcitability and limbic seizure activity (Butler et al., 1995). These 
findings suggest that altered function of CaM kinase II may contribute to the underlying 
mechanisms of these conditions. 
Our data demonstrate a long-lasting decrease in activity of CaM kinase II in 
association with the chronic expression of epileptiform activity exhibited in low Mg++ 
treated hippocampal neuronal cultures. The decrement in enzyme activity is detected 
immediately after induction of SRSs and continues for as long as 5 days following low Mg++ 
treatment. We observed a decrease in CaM kinase II a (50 kDa) and p (60 kDa) subunit 
immunoreactivity in association with the "epileptic" condition of these hippocampal 
neuronal cultures. These results are in agreement with the findings from other studies 
demonstrating a decrease in both activity (Bronstein et al., 1988; Churn et al., 1991; Churn 
et al., 1997; Goldenring et al., 1986; Kochan et al., 1997; Perlin et al., 1992; Wasterlain and 
Farber, 1984; Wasterlain et al., 1992) and immunoreactivity (Bronstein et al., 1990) of CaM 
kinase II in models of seizures and epilepsy. 
The mechanism(s) involved in the observed decrease in activity ofCaM kinase II in 
association with SRSs is not clear. Several studies have demonstrated that a post­
translational modification of the CaM kinase II enzyme occurs in association with models 
of stroke (Churn, 1995; Churn et al., 1993a; Churn et al., 1992a) and seizures (Perlin et al., 
1992; Churn et al., 1991). A unique characteristic of CaM kinase II is its ability to undergo 
autophosphorylation, creating an autonomous form of the enzyme which enables it to 
continue phosphorylating substrates in a ca++/calmodulin-independent manner. It is believed 
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that autophosphorylation of CaM kinase II can result in a number of effects on the 
holoenzyme. These include conformational changes, subcellular translocation, substrate 
specificity, calmodulin binding, susceptibility to proteolysis and alterations in activity 
(Dunkley, 1991). 
Our results demonstrate a significant decrease in endogenous Ca++/calmodulin­
dependent phosphorylation of the a (50 kDa) and P (60 kDa) subunits of CaM kinase II in 
association with SRS activity in hippocampal neuronal cultures. This inhibition of CaM 
kinase II-dependent autophosphorylation could reflect a post-translational modification of 
the enzyme. From these results we could postulate that the SRS-associated decrease in the 
ability ofCaM kinase II to become autonomous may contribute to possible outcomes. First, 
a decrease in enzyme activity demonstrated by suppressed substrate-dependent 
phosphorylation and secondly, altered protein stability exhibited by decreased 
immunoreactivity for the a and p subunits. Further investigations are warranted to determine 
what specific modifications of the CaM kinase II enzyme complex contribute to the decrease 
in activity observed in this in vitro hippocampal neuronal culture model of epilepsy. 
The low Mf+ -induced expression of epileptiforrn activity in hippocampal cultures 
has previously been shown to be an NMDA receptor, Ca++_dependent mechanism (Sombati 
and DeLorenzo, 1995). Our data demonstrate that the addition of25 µM D-APV (NMDA 
receptor antagonist) during low Mg++ exposure results in preserving the activity of CaM 
kinase II. This finding shows that the decrease in CaM kinase II activity directly correlates 
with the induction of SRS activity exhibited in the hippocampal culture model of epilepsy. 
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Recent investigations have revealed that the CaM kinase II transduction pathway acts 
to positively modulate GABAA receptor function (Aguayo et al., 1998; Chum and 
DeLorenzo, 1996; Kano et al., 1996; Wang et al., 1995). Our results demonstrate a decrease 
in both CaM kinase II activity and GABAA receptor expression in the hippocampal neuronal 
culture model of epilepsy. These alterations occur in conjunction with a decrease in GABAA 
receptor function previously demonstrated in this model (Gibbs et al., 1997b). In view of 
these findings, we could speculate that the decrease in function of these two systems could 
be directly related. To address this issue, we carried out studies to determine if CaM kinase 
II acts to modulate GABAA receptor function in hippocampal neuronal cultures. Our data 
demonstrate that suppression of CaM kinase II activity by treatment with either an antisense 
oligonucleotide directed towards a CaM kinase II or the specific inhibitor KN93 results in 
a significant decrease in IPSC amplitude. The analysis of the IPSC is indicative of GABAA 
receptor function at the postsynaptic membrane. Therefore, these findings show that CaM 
kinase II can regulate GABAA receptor function in hippocampal neuronal cultures. 
The premise that the observed decrease in both CaM kinase II activity and GABAA 
receptor expression and function in this in vitro model of epilepsy are directly related is a 
challenging and complex query. Kinase-dependent regulation ofGABAA receptor function 
has been well established (Sigel, 1995). Moreover, the CaM kinase II transduction pathway 
has been shown to enhance GABAA receptor function (Chum and DeLorenzo, 1996; Kano 
et al., 1996; Wang et al., 1995). Although it has been demonstrated that the �l, �2 and y2 
subunits of the GABAA receptor channel contain consensus sites for CaM kinase II-
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dependent phosphorylation (McDonald and Moss, 1994 ), no direct evidence has been shown 
to indicate this is a mechanism involved in the regulation of receptor function by this enzyme 
pathway. The multifunctional nature of CaM kinase II allows for a myriad of possibilities 
for its role in regulating GABAA receptor function, ranging from transcriptional mechanisms 
to post-translational modification. Further investigations are required to determine if a direct 
relationship between the decrease in CaM kinase II activity and GABAA receptor expression 
and function exists in association with the "epileptic" condition of this hippocampal culture 
model, and if so, what intracellular pathways are involved in this mechanism. 
Epileptogenesis is a complex process. This thesis study demonstrates for the first 
time that enduring decreases in GABAA a. receptor subunit expression and activity of CaM 
kinase II are associated with the induction of SRS activity in an in vitro model of epilepsy. 
These alterations may contribute to the underlying mechanisms responsible for the chronic 
epileptiform activity expressed in these neuronal cultures. We also demonstrate that 
experimental suppression of CaM kinase II activity in hippocampal cultures results in a 
reduction of GABAA receptor function. An increased understanding of the mechanisms 
which underlie epilepsy and the seizures associated with it will allow for the development 
of more efficacious therapeutic interventions for these conditions. 
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